<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:CIK0002047455="http://CIK0002047455/20260531"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cik0002047455-20260531.xsd" xlink:type="simple"/>
    <context id="From2025-12-01to2026-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_OrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:OrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifthOfOneOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RightsEachRightEntitlingHolderToReceiveOnefifthOfOneOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-07-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2026-07-13</instant>
        </period>
    </context>
    <context id="AsOf2026-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2026-05-31_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="From2026-03-012026-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-05-31_custom_RedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-05-31_custom_NonRedeemableSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-11-30_custom_OrdinarySharesMember1061113093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-30</instant>
        </period>
    </context>
    <context id="AsOf2026-02-28_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="AsOf2026-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="AsOf2026-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="AsOf2026-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2026-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-12-012026-02-28_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-02-28_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-31_custom_OrdinarySharesMember1061113156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2026-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2026-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-31_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="From2025-03-012025-03-19_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-19</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-03-19_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-19</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-03-19_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-19</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-19_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-19</instant>
        </period>
    </context>
    <context id="AsOf2026-05-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="AsOf2026-06-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2026-06-23</instant>
        </period>
    </context>
    <context id="AsOf2026-05-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_PubCoOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:PubCoOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-31_custom_SponsorReceivedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:SponsorReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-31</instant>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">CIK0002047455:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-06-012025-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_custom_RedeemablesSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemablesSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_custom_RedeemablesSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemablesSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2026-03-012026-05-31_custom_NonRedeemableClassAOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableClassAOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31_custom_NonRedeemableClassAOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableClassAOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_RedeemablesSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemablesSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-05-31_custom_RedeemablesSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:RedeemablesSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_NonRedeemableClassAOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableClassAOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-05-31_custom_NonRedeemableClassAOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">CIK0002047455:NonRedeemableClassAOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-19_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-19</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-05_custom_FounderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">CIK0002047455:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-05_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-05</instant>
        </period>
    </context>
    <context id="From2025-02-032025-02-12_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-03</startDate>
            <endDate>2025-02-12</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-12_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="From2025-03-012025-03-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-03-17_custom_FounderMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-03-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2024-11-05</instant>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_custom_SponsorMember_us-gaap_AdministrativeServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:AdministrativeServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">CIK0002047455:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2025-12-012026-05-31_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2026-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-11-30_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-11-30</endDate>
        </period>
    </context>
    <context id="From2025-03-032025-03-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <startDate>2025-03-03</startDate>
            <endDate>2025-03-19</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2025-04-22</instant>
        </period>
    </context>
    <context id="AsOf2025-04-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2025-04-29</instant>
        </period>
    </context>
    <context id="AsOf2025-07-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2025-07-18</instant>
        </period>
    </context>
    <context id="AsOf2026-06-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002047455</identifier>
        </entity>
        <period>
            <instant>2026-06-25</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-12-01to2026-05-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-12-01to2026-05-31" id="Fact000004">--11-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2025-12-01to2026-05-31" id="Fact000005">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-12-01to2026-05-31" id="Fact000006">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-12-01to2026-05-31" id="Fact000007">0002047455</dei:EntityCentralIndexKey>
    <CIK0002047455:DueFromRelatedParty
      contextRef="AsOf2026-05-31"
      id="xdx2ixbrl0055"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2026-05-31"
      id="xdx2ixbrl0064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-05-31"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-11-30"
      id="xdx2ixbrl0134"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-11-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0246"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-12-012026-02-28_custom_OrdinarySharesMember"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-12-012026-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-12-012026-02-28_custom_OrdinarySharesMember"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-12-012026-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2026-03-012026-05-31_custom_OrdinarySharesMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2026-03-012026-05-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-03-012026-05-31_custom_OrdinarySharesMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2026-03-012026-05-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-05-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-02-28_custom_OrdinarySharesMember"
      id="xdx2ixbrl0293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:IssuanceOfPrivatePlacementUnits
      contextRef="From2025-03-012025-05-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:IssuanceOfPublicRightsNetOfIssuanceCosts
      contextRef="From2025-03-012025-05-31_custom_OrdinarySharesMember"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:IssuanceOfPublicRightsNetOfIssuanceCosts
      contextRef="From2025-03-012025-05-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-03-012025-05-31_custom_OrdinarySharesMember"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-03-012025-05-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:AccretionOfAdditionalPaidinCapitalToAccumulatedDeficit
      contextRef="From2025-03-012025-05-31_custom_OrdinarySharesMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:AccretionOfAdditionalPaidinCapitalToAccumulatedDeficit
      contextRef="From2025-03-012025-05-31"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-03-012025-05-31_custom_OrdinarySharesMember"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2025-03-012025-05-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-05-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0333"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestIncomeShortTermInvestmentOther
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2024-12-012025-05-31"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:PurchaseOfShorttermInvestment
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:PaymentsForPurchaseOfOtherAsset1
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:DueFromRelatedPartys
      contextRef="From2024-12-012025-05-31"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:DueToRelatedPartys
      contextRef="From2024-12-012025-05-31"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:PaymentsForFee
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficits
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <CIK0002047455:DeferredUnderwritingFeePayable
      contextRef="From2025-12-01to2026-05-31"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2025-12-01to2026-05-31" id="Fact000013">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2025-12-01to2026-05-31" id="Fact000014">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-12-01to2026-05-31" id="Fact000015">2026-05-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-12-01to2026-05-31" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-12-01to2026-05-31" id="Fact000017">001-42555</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-12-01to2026-05-31" id="Fact000018">Quartzsea Acquisition Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-12-01to2026-05-31" id="Fact000019">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-12-01to2026-05-31" id="Fact000020">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-12-01to2026-05-31" id="Fact000021">1185 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-12-01to2026-05-31" id="Fact000022">Suite 304</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-12-01to2026-05-31" id="Fact000023">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-12-01to2026-05-31" id="Fact000024">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-12-01to2026-05-31" id="Fact000025">10036</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-12-01to2026-05-31" id="Fact000026">(212)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-12-01to2026-05-31" id="Fact000027">612-1400</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2025-12-01to2026-05-31" id="Fact000028">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-12-01to2026-05-31" id="Fact000029">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-12-01to2026-05-31" id="Fact000030">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-12-01to2026-05-31" id="Fact000031">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-12-01to2026-05-31" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2025-12-01to2026-05-31" id="Fact000033">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="From2025-12-01to2026-05-31" id="Fact000034">true</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="From2025-12-012026-05-31_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember"
      id="Fact000035">Units, each consisting of one ordinary share and one right</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-012026-05-31_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember"
      id="Fact000036">QSEAU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-12-012026-05-31_custom_UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember"
      id="Fact000037">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-12-012026-05-31_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000038">Ordinary Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-012026-05-31_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000039">QSEA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-12-012026-05-31_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000040">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-12-012026-05-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifthOfOneOrdinaryShareMember"
      id="Fact000041">Rights, each right entitling the holder to receive one-fifth of one ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-12-012026-05-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifthOfOneOrdinaryShareMember"
      id="Fact000042">QSEAR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-12-012026-05-31_custom_RightsEachRightEntitlingHolderToReceiveOnefifthOfOneOrdinaryShareMember"
      id="Fact000043">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-07-13"
      decimals="INF"
      id="Fact000044"
      unitRef="Shares">10134518</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000052"
      unitRef="USD">5156</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000053"
      unitRef="USD">12095</us-gaap:Cash>
    <CIK0002047455:DueFromRelatedParty
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000056"
      unitRef="USD">19575</CIK0002047455:DueFromRelatedParty>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000058"
      unitRef="USD">107306</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000059"
      unitRef="USD">60824</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000061"
      unitRef="USD">112462</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000062"
      unitRef="USD">92494</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000065"
      unitRef="USD">41699</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">86732878</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000068"
      unitRef="USD">85202732</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000070"
      unitRef="USD">86845340</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">85336925</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000079"
      unitRef="USD">180000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000080"
      unitRef="USD">60000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000082"
      unitRef="USD">793188</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000083"
      unitRef="USD">681883</us-gaap:AccruedLiabilitiesCurrent>
    <CIK0002047455:DueToRelatedParty
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000085"
      unitRef="USD">174352</CIK0002047455:DueToRelatedParty>
    <CIK0002047455:DueToRelatedParty
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000086"
      unitRef="USD">-0</CIK0002047455:DueToRelatedParty>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000088"
      unitRef="USD">1147540</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">741883</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000091"
      unitRef="USD">3312000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000092"
      unitRef="USD">3312000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000094"
      unitRef="USD">4459540</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000095"
      unitRef="USD">4053883</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2026-05-31_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000103"
      unitRef="Shares">8280000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2025-11-30_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000105"
      unitRef="Shares">8280000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2026-05-31_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000107"
      unitRef="USDPShares">10.47</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2025-11-30_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000109"
      unitRef="USDPShares">10.29</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000100"
      unitRef="USD">86732878</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000101"
      unitRef="USD">85202732</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000117"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000119"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000121"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000123"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000125"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000127"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000129"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000131"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000114"
      unitRef="USD">313</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000115"
      unitRef="USD">313</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000136"
      unitRef="USD">-4347391</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000137"
      unitRef="USD">-3920003</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000139"
      unitRef="USD">-4347078</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000140"
      unitRef="USD">-3919690</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000142"
      unitRef="USD">86845340</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000143"
      unitRef="USD">85336925</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000145"
      unitRef="USD">196589</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000146"
      unitRef="USD">727747</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000147"
      unitRef="USD">427450</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000148"
      unitRef="USD">761251</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000150"
      unitRef="USD">-196589</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000151"
      unitRef="USD">-727747</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000152"
      unitRef="USD">-427450</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000153"
      unitRef="USD">-761251</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000160"
      unitRef="USD">24</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000161"
      unitRef="USD">7655</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000162"
      unitRef="USD">61</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000163"
      unitRef="USD">9904</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000165"
      unitRef="USD">770237</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000166"
      unitRef="USD">692945</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000167"
      unitRef="USD">1530146</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000168"
      unitRef="USD">692945</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherIncome
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000170"
      unitRef="USD">770261</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000171"
      unitRef="USD">700600</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000172"
      unitRef="USD">1530207</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000173"
      unitRef="USD">702849</us-gaap:OtherIncome>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000175"
      unitRef="USD">573672</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000176"
      unitRef="USD">-27147</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000177"
      unitRef="USD">1102757</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000178"
      unitRef="USD">-58402</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-03-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000180"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-03-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000182"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-03-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000184"
      unitRef="Shares">6570000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-03-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000186"
      unitRef="Shares">6570000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-12-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000188"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-12-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000190"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-12-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000192"
      unitRef="Shares">3321099</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-12-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000194"
      unitRef="Shares">3321099</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-03-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000196"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-03-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000198"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-03-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000200"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-03-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000202"
      unitRef="USDPShares">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-12-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000204"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-12-012026-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000206"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-12-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000208"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-12-012025-05-31_custom_RedeemableSharesMember"
      decimals="INF"
      id="Fact000210"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000212"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000216"
      unitRef="Shares">3003942</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000218"
      unitRef="Shares">3003942</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000220"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000222"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000224"
      unitRef="Shares">2764630</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000226"
      unitRef="Shares">2764630</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000228"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000230"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000232"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000234"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000236"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000238"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000240"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000242"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-11-30_custom_OrdinarySharesMember1061113093"
      decimals="INF"
      id="Fact000250"
      unitRef="Shares">3129900</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-11-30_custom_OrdinarySharesMember1061113093"
      decimals="0"
      id="Fact000245"
      unitRef="USD">313</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000247"
      unitRef="USD">-3920003</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000248"
      unitRef="USD">-3919690</us-gaap:StockholdersEquity>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-12-012026-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000254"
      unitRef="USD">-759908</CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-12-012026-02-28"
      decimals="0"
      id="Fact000255"
      unitRef="USD">-759908</CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue>
    <us-gaap:ProfitLoss
      contextRef="From2025-12-012026-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000259"
      unitRef="USD">529085</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-12-012026-02-28"
      decimals="0"
      id="Fact000260"
      unitRef="USD">529085</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-02-28_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000267"
      unitRef="Shares">3129900</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-02-28_custom_OrdinarySharesMember"
      decimals="0"
      id="Fact000262"
      unitRef="USD">313</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000264"
      unitRef="USD">-4150826</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-02-28"
      decimals="0"
      id="Fact000265"
      unitRef="USD">-4150513</us-gaap:StockholdersEquity>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2026-03-012026-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000271"
      unitRef="USD">-770237</CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000272"
      unitRef="USD">-770237</CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue>
    <us-gaap:ProfitLoss
      contextRef="From2026-03-012026-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000276"
      unitRef="USD">573672</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000277"
      unitRef="USD">573672</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-05-31_custom_OrdinarySharesMember1061113156"
      decimals="INF"
      id="Fact000284"
      unitRef="Shares">3129900</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-05-31_custom_OrdinarySharesMember1061113156"
      decimals="0"
      id="Fact000279"
      unitRef="USD">313</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000281"
      unitRef="USD">-4347391</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000282"
      unitRef="USD">-4347078</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-11-30_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000291"
      unitRef="Shares">2898000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_custom_OrdinarySharesMember"
      decimals="0"
      id="Fact000286"
      unitRef="USD">290</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000287"
      unitRef="USD">24710</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000288"
      unitRef="USD">-10166</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000289"
      unitRef="USD">14834</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000295"
      unitRef="USD">-31255</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-12-012025-02-28"
      decimals="0"
      id="Fact000296"
      unitRef="USD">-31255</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-02-28_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000303"
      unitRef="Shares">2898000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_custom_OrdinarySharesMember"
      decimals="0"
      id="Fact000298"
      unitRef="USD">290</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000299"
      unitRef="USD">24710</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000300"
      unitRef="USD">-41421</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000301"
      unitRef="USD">-16421</us-gaap:StockholdersEquity>
    <CIK0002047455:IssuanceOfPrivatePlacementUnitsShares
      contextRef="From2025-03-012025-05-31_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000310"
      unitRef="Shares">231900</CIK0002047455:IssuanceOfPrivatePlacementUnitsShares>
    <CIK0002047455:IssuanceOfPrivatePlacementUnits
      contextRef="From2025-03-012025-05-31_custom_OrdinarySharesMember"
      decimals="0"
      id="Fact000305"
      unitRef="USD">23</CIK0002047455:IssuanceOfPrivatePlacementUnits>
    <CIK0002047455:IssuanceOfPrivatePlacementUnits
      contextRef="From2025-03-012025-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000306"
      unitRef="USD">2318977</CIK0002047455:IssuanceOfPrivatePlacementUnits>
    <CIK0002047455:IssuanceOfPrivatePlacementUnits
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000308"
      unitRef="USD">2319000</CIK0002047455:IssuanceOfPrivatePlacementUnits>
    <CIK0002047455:IssuanceOfPublicRightsNetOfIssuanceCosts
      contextRef="From2025-03-012025-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000313"
      unitRef="USD">1804080</CIK0002047455:IssuanceOfPublicRightsNetOfIssuanceCosts>
    <CIK0002047455:IssuanceOfPublicRightsNetOfIssuanceCosts
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">1804080</CIK0002047455:IssuanceOfPublicRightsNetOfIssuanceCosts>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-03-012025-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000318"
      unitRef="USD">-6858776</CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000320"
      unitRef="USD">-6858776</CIK0002047455:RemeasurementOfCarryingValueToRedemptionValue>
    <CIK0002047455:AccretionOfAdditionalPaidinCapitalToAccumulatedDeficit
      contextRef="From2025-03-012025-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000323"
      unitRef="USD">2711009</CIK0002047455:AccretionOfAdditionalPaidinCapitalToAccumulatedDeficit>
    <CIK0002047455:AccretionOfAdditionalPaidinCapitalToAccumulatedDeficit
      contextRef="From2025-03-012025-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000324"
      unitRef="USD">-2711009</CIK0002047455:AccretionOfAdditionalPaidinCapitalToAccumulatedDeficit>
    <us-gaap:ProfitLoss
      contextRef="From2025-03-012025-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000329"
      unitRef="USD">-27147</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000330"
      unitRef="USD">-27147</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-05-31_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000337"
      unitRef="Shares">3129900</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-05-31_custom_OrdinarySharesMember"
      decimals="0"
      id="Fact000332"
      unitRef="USD">313</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000334"
      unitRef="USD">-2779577</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-05-31"
      decimals="0"
      id="Fact000335"
      unitRef="USD">-2779264</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000343"
      unitRef="USD">1102757</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000344"
      unitRef="USD">-58402</us-gaap:NetIncomeLoss>
    <us-gaap:InterestIncomeShortTermInvestmentOther
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000350"
      unitRef="USD">5037</us-gaap:InterestIncomeShortTermInvestmentOther>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000352"
      unitRef="USD">1530146</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000353"
      unitRef="USD">692945</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000358"
      unitRef="USD">4782</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000359"
      unitRef="USD">123892</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000361"
      unitRef="USD">120000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000364"
      unitRef="USD">111305</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000365"
      unitRef="USD">259149</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000367"
      unitRef="USD">-200866</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000368"
      unitRef="USD">-621127</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <CIK0002047455:PurchaseOfShorttermInvestment
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000374"
      unitRef="USD">600000</CIK0002047455:PurchaseOfShorttermInvestment>
    <CIK0002047455:PaymentsForPurchaseOfOtherAsset1
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000377"
      unitRef="USD">82800000</CIK0002047455:PaymentsForPurchaseOfOtherAsset1>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000380"
      unitRef="USD">-83400000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000386"
      unitRef="USD">82800000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000389"
      unitRef="USD">2319000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <CIK0002047455:DueFromRelatedPartys
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000391"
      unitRef="USD">19575</CIK0002047455:DueFromRelatedPartys>
    <CIK0002047455:DueToRelatedPartys
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000394"
      unitRef="USD">174352</CIK0002047455:DueToRelatedPartys>
    <CIK0002047455:PaymentsForFee
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000398"
      unitRef="USD">586500</CIK0002047455:PaymentsForFee>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000401"
      unitRef="USD">500000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000404"
      unitRef="USD">273251</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000406"
      unitRef="USD">193927</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000407"
      unitRef="USD">83759249</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000409"
      unitRef="USD">-6939</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000410"
      unitRef="USD">-261878</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000412"
      unitRef="USD">12095</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-11-30"
      decimals="0"
      id="Fact000413"
      unitRef="USD">311000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000415"
      unitRef="USD">5156</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-05-31"
      decimals="0"
      id="Fact000416"
      unitRef="USD">49122</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <CIK0002047455:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficits
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000422"
      unitRef="USD">2711009</CIK0002047455:AccretionOfAdditionalPaidInCapitalToAccumulatedDeficits>
    <CIK0002047455:RemeasurementOfCarryingValuesToRedemptionsValue
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000424"
      unitRef="USD">1530146</CIK0002047455:RemeasurementOfCarryingValuesToRedemptionsValue>
    <CIK0002047455:RemeasurementOfCarryingValuesToRedemptionsValue
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000425"
      unitRef="USD">6858776</CIK0002047455:RemeasurementOfCarryingValuesToRedemptionsValue>
    <CIK0002047455:DeferredUnderwritingFeePayable
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000428"
      unitRef="USD">3312000</CIK0002047455:DeferredUnderwritingFeePayable>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000430">&lt;p id="xdx_800_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zeGx5A99KCh8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 1 &#x2014; &lt;span id="xdx_82F_zQ5duH0KxkPa"&gt;Organization, Business Operations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Quartzsea Acquisition Corporation (the &#x201c;Company&#x201d;&lt;/span&gt; or &#x201c;&lt;span style="font-size: 10pt"&gt;Quartzsea&#x201d;) is a blank check company incorporated under the laws of the Cayman Islands with limited liability on November&#160;5, 2024. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (&#x201c;Business Combination&#x201d;). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of May&#160;31, 2026, the Company had not commenced any operations. For the period from November&#160;5, 2024 (inception) through May&#160;31, 2026, the Company&#x2019;s efforts have been limited to organizational activities as well as activities related to completing the initial public offering (&#x201c;IPO&#x201d;) and subsequent to the IPO, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of dividend and/or interest income from the proceeds derived from the IPO and sale of Private Placement Units (as defined below). The Company has selected November&#160;30 as its fiscal year end.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s sponsor is Blue Jay Investment LLC (the &#x201c;Sponsor&#x201d;), a Delaware limited liability company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The registration statement for the IPO was declared effective on March&#160;14, 2025. On March&#160;19, 2025, the Company consummated its IPO of &lt;span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zrloQYPnt4v8" title="Sale of units in initial public offering"&gt;8,280,000&lt;/span&gt; units (the &#x201c;Public Units&#x201d;), including the full exercise of the over-allotment option of &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zp5EGUhb6r6h" title="Sale of units in initial public offering"&gt;1,080,000&lt;/span&gt; Units granted to the underwriters. The Public Units were sold at an offering price of $10.00 per unit generating gross proceeds of $&lt;span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziLxA5v7nDN9" title="Sale of units in initial public offering aggregate amount"&gt;82,800,000&lt;/span&gt;. Simultaneously with the IPO, the Company sold to its Sponsor &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwLfWWMXh682" title="Sale of units in initial public offering"&gt;231,900&lt;/span&gt; units at $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z8ii8uLhlGSf" title="Sale of units per share"&gt;10.00&lt;/span&gt; per unit (the &#x201c;Private Units&#x201d;) in a private placement generating total gross proceeds of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0p0_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zwPOasZdNPb6" title="Sale of units in initial public offering aggregate amount"&gt;2,319,000&lt;/span&gt;, which is described in Note 4.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Transaction costs amounted to $&lt;span id="xdx_906_ecustom--TransactionCosts_pp0p0_c20251201__20260531_zzaJTlxE58l6" title="Transaction costs"&gt;4,361,752&lt;/span&gt; consisting of $&lt;span id="xdx_906_eus-gaap--ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_pp0p0_c20251201__20260531_zqcSp3LoMCvf" title="Underwriting commissions"&gt;3,898,500&lt;/span&gt; of underwriting commissions, $&lt;span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_c20260531_zG84LioWTDS7" title="Cash"&gt;586,500&lt;/span&gt; of which was paid in cash at the closing date of the IPO and $&lt;span id="xdx_901_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20251201__20260531_zuKaFtjr5vje" title="Offering costs"&gt;463,252&lt;/span&gt; of legal and other offering costs. At the IPO date, cash of $&lt;span id="xdx_903_eus-gaap--AssetsHeldInTrust_iI_pp0p0_c20260531_zch2ECNRRkZ1" title="Cash held in trust"&gt;1,245,878&lt;/span&gt; was held outside of the Trust Account (as defined below) and is available for working capital purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the &#x201c;Investment Company Act&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Upon the closing of the IPO, management has agreed that at least $&lt;span id="xdx_90F_eus-gaap--SharePrice_iI_c20260531__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zefsPCVXbS3k" title="Share Price"&gt;10.00&lt;/span&gt; per public share underlying Units sold in the IPO will be held into a U.S.-based trust account (&#x201c;Trust Account&#x201d;). The funds held in the Trust Account will be invested only in U.S. government treasury bills with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act of 1940 and which invest solely in U.S. Treasuries. The Trust Fund will be deposited into the Trust Account in the U.S. to be released only in the event of either: (i) the consummation of a Business Combination or (ii) the Company&#x2019;s failure to complete a Business Combination within the applicable period of time.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company will provide its holders of the outstanding Public Shares (the &#x201c;Public shareholders&#x201d;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations). The Public Shares subject to redemption was recorded at a redemption value and classified as temporary equity upon the completion of the IPO on March&#160;19, 2025 in accordance with the Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Company&#x2019;s Sponsor and any of the Company&#x2019;s officers or directors that may hold Founder Shares (as defined in Note 5) (the &#x201c;Initial Shareholders&#x201d;) and the underwriters have agreed (a) to vote their Founder Shares, Private Shares (as defined in Note 4), and any Public Shares purchased during or after the IPO (other than Public Shares purchased outside of a redemption offer which may not be voted in favor of approving the business combination transaction in accordance with the requirements of Rule&#160;14e-5 under the Exchange Act and any SEC interpretations or guidance relating thereto) in favor of approving a Business Combination and (b) not to convert any shares (including the Founder Shares) in connection with a shareholder vote to approve, or sell the shares to the Company in any tender offer in connection with, a proposed Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Initial Shareholders have agreed (a) to waive their redemption rights with respect to the Founder Shares, Private Shares, and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of, an amendment to the amended and restated memorandum and articles of association that would affect the substance or timing of the Company&#x2019;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company initially has 15 months from the
consummation of the IPO, or June&#160;19, 2026, to consummate its initial business combination (&#x201c;Combination Period&#x201d;).
If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations
except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account
including interest (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, which
redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further
liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of the Company&#x2019;s remaining shareholders and the Company&#x2019;s board of directors,
dissolve and liquidate, subject in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of
creditors and the requirements of other applicable law.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;On June
23, 2026, the Company held an extraordinary general meeting at which its shareholders approved, among other things, an amendment to the
Existing Charter extending the date by which Quartzsea must consummate an initial business combination from June 19, 2026 to October
19, 2026 on a monthly basis by depositing an amount equal to lesser of (i) &lt;span id="xdx_90F_ecustom--Deposit_iI_c20260623_z6AZSvC5WF65" title="Deposit"&gt;$175,000&lt;/span&gt; or (ii) $&lt;span id="xdx_907_ecustom--OutstandingPublicShare_iI_c20260531_z59afm0doUqf" title="Outstanding public share"&gt;0.033&lt;/span&gt; per outstanding public share. In connection
with the extraordinary general meeting, holders of &lt;span id="xdx_90F_ecustom--ExtraordinaryGeneralMeeting_c20251201__20260531_zhr7TrG0VuNf" title="Extraordinary general meeting"&gt;1,275,382&lt;/span&gt; Quartzsea ordinary shares properly exercised their redemption rights. Such
shares were redeemed at a price of approximately $&lt;span id="xdx_906_ecustom--AggregatePerShare_iI_c20260531_zzcNSFmHctE4" title="Aggregate per share"&gt;10.50&lt;/span&gt; per share, for an aggregate redemption payment of $&lt;span id="xdx_90A_ecustom--PaymentRedemptionValue_c20251201__20260531_zxdi8CbDkjY9" title="Payment redemption value"&gt;13,391,956&lt;/span&gt; from
the trust account. Following the redemptions, &lt;span id="xdx_903_ecustom--PaymentRedemptionShares_c20251201__20260531_z1miBbCrI8Rl" title="Payment redemption shares"&gt;10,134,518&lt;/span&gt; Quartzsea ordinary shares were issued and outstanding, and $&lt;span id="xdx_903_ecustom--Deposit_iI_c20260531_zgYpYDLKDno2" title="Deposit"&gt;73,550,934&lt;/span&gt;
remained on deposit in the trust account. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Sponsor and the other Initial Shareholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares, and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or the other Initial Shareholders acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $&lt;span id="xdx_904_eus-gaap--SharePrice_iI_c20260531__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zgMY419Pr9R6" title="Share Price"&gt;10.00&lt;/span&gt; per public share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company&#x2019;s indemnity of the underwriters of IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Subsidiaries&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 20, 2025, Cuisine Universal Packaging Solution,
a Cayman Islands exempted company and wholly-owned subsidiary of Quartzsea (the &#x201c;Purchaser&#x201d;), was formed to be the surviving
company after the merger of a contemplated business combination. On May 7, 2026, the Purchaser changed its name to &#x201c;Eight Directions
Global Limited&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 21, 2025, CUPS Sub Limited, a Cayman Islands exempted company and wholly-owned subsidiary of the Purchaser was formed to be the Merger Sub in connection with a contemplated business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Both subsidiaries have no principal operations or revenue producing activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Termination of the Merger Agreement with Broadway
Tech&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 6, 2025, Quartzsea, Cuisine Universal
Packaging Solution, a Cayman Islands exempted company and wholly-owned subsidiary of the Quartzsea, and CUPS Sub Limited, a Cayman
Islands exempted company and wholly-owned subsidiary of the Purchaser (the &#x201c;Merger Sub&#x201d;), entered into a Merger
Agreement (the &#x201c;Merger Agreement&#x201d;) with the Broadway Technology Inc, a Cayman Islands exempted company (the
&#x201c;Broadway Tech&#x201d;), a leading manufacturer of high-quality PET (polyethylene terephthalate) cups and lids through its
operating subsidiary Zhejiang Gaokai New Materials Co., Ltd., Pivot Technology Holding Inc, a British Virgin Islands
(&#x201c;BVI&#x201d;) business company organized under the Laws of the British Virgin Islands, and Zenith Technology International
Inc, a BVI business company also organized under the Laws of the British Virgin Islands (each, a &#x201c;Principal Shareholder&#x201d;
and collectively, the &#x201c;Principal Shareholders&#x201d;), Fan Zhang, an individual, solely in his capacity as the shareholder
representative, agent and attorney-in-fact of the Principal Shareholders. Capitalized terms used herein but not defined herein shall
have the meanings ascribed to them in the Former Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the Merger Agreement, Broadway
Tech agreed to provide Blue Jay Investment LLC, the sponsor of Quartzsea, a working capital loan of $&lt;span id="xdx_90F_ecustom--WorkingCapitalLoan_iI_c20251130_zRgYG6YlcL3c" title="Working capital loan"&gt;500,000&lt;/span&gt;
in exchange for promissory note issued by the sponsor. As of May&#160;31, 2026, the Sponsor received $&lt;span id="xdx_907_ecustom--TransactionExpenses_iI_c20260531_zEEPsZGjyE6b" title="Transaction expenses"&gt;500,000&lt;/span&gt;
under such arrangement and funded approximately $&lt;span id="xdx_90B_ecustom--TransactionExpenses_iI_c20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zNplVVqxBaH7" title="Transaction expenses"&gt;174,000&lt;/span&gt; Quartzsea&#x2019;s transaction expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 17, 2026, the Company entered into a
Termination, Settlement and Mutual General Release Agreement with Broadway Tech, pursuant to which the Merger Agreement and the transactions
contemplated thereby were terminated in their entirety, effective as of March 17, 2026. The termination agreement provides for mutual
releases of claims relating to the Merger Agreement and the proposed transaction. The parties entered into the termination agreement due
to the prolonged China Securities Regulatory Commission approval process and related PRC regulatory uncertainty. No termination fees were
payable by either party in connection with the termination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;New Merger Agreement with Eight Directions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Quartzsea has entered into an agreement and
plan of merger, dated as of May&#160;13, 2026 (as it may be amended from time to time, the &#x201c;New Merger Agreement&#x201d;),
which provides for a Business Combination involving Quartzsea and Eight Directions Technology Limited, a Cayman Islands exempted
company (&#x201c;Eight Directions&#x201d;). Pursuant to the Merger Agreement, the Business Combination will be effected in two steps:
(i) subject to the approval and adoption of the Merger Agreement, and PubCo Charter Proposal by the shareholders of Quartzsea,
Quartzsea will merge with and into Eight Directions Global Limited, a Cayman Islands exempted company and wholly owned subsidiary of
Quartzsea (&#x201c;PubCo&#x201d;), with PubCo remaining as the surviving publicly traded entity (the &#x201c;SPAC Merger&#x201d;); (ii)
concurrently with the SPAC Merger, CUPS Sub Limited, a Cayman Islands exempted company and wholly owned subsidiary of the PubCo
(&#x201c;Merger Sub&#x201d;), will be merged with and into Eight Directions, with Eight Directions and its subsidiaries surviving the
merger as a wholly owned subsidiary of PubCo (the &#x201c;Acquisition Merger&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The aggregate consideration for the Acquisition
Merger is $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20251201__20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PubCoOrdinarySharesMember_zghPANbczT52" title="Number of value issued"&gt;515,000,000&lt;/span&gt;, payable in the form of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251201__20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PubCoOrdinarySharesMember_z4SNBUDhgUL3" title="Number of shares issued"&gt;51,500,000&lt;/span&gt; newly issued PubCo Ordinary Shares (the &#x201c;Closing Payment Shares&#x201d;)
valued at $10.00 per share to Eight Directions and its shareholders. At the closing of the Acquisition Merger, the issued and outstanding
shares in Eight Directions held by the former Eight Directions shareholders will be cancelled and cease to exist, in exchange for the
issuance of an aggregate of &lt;span id="xdx_903_ecustom--PubcoClassOrdinaryShares_c20251201__20260531_zQgUKIedHNWh" title="PubCo class a ordinary shares"&gt;25,750,000&lt;/span&gt; PubCo Class A Ordinary Shares and &lt;span id="xdx_907_ecustom--PubcoClassBOrdinaryShares_c20251201__20260531_ztlVY6avAON4" title="PubCo class b ordinary shares"&gt;25,750,000&lt;/span&gt; PubCo Class B Ordinary Shares. At the closing of the
Acquisition Merger, the one fully paid share in Merger Sub held by PubCo will become one fully paid share in the surviving corporation,
so that Eight Directions will become a wholly owned subsidiary of PubCo.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Upon the closing of the Business Combination,
ordinary shares of PubCo will be reclassified into class A ordinary shares (&#x201c;PubCo Class A Ordinary Shares&#x201d;) and class B ordinary
shares (&#x201c;PubCo Class B Ordinary Shares,&#x201d; together with PubCo Class A Ordinary Shares, collectively &#x201c;PubCo Ordinary Shares&#x201d;)
where each PubCo Class A Ordinary Share shall be entitled to one (1) vote on all matters subject to vote at general meetings of the post-Business
Combination company and each PubCo Class B Ordinary Share shall be entitled to ten (10) votes on all matters subject to vote at all general
meetings of the post-Business Combination company. At the closing of the Business Combination, the former Quartzsea shareholders will
receive one PubCo Class A Ordinary Share for each Quartzsea Ordinary Share and one-fifth (1/5) of one PubCo Class A Ordinary Share for each Quartzsea
Right, and the former shareholders of Eight Directions will receive an aggregate of &lt;span id="xdx_903_ecustom--PubcoClassOrdinaryShares_c20251201__20260531_zs61wjrXH7Jc" title="PubCo class a ordinary shares"&gt;25,750,000&lt;/span&gt; PubCo
Class A Ordinary Shares and &lt;span id="xdx_907_ecustom--PubcoClassBOrdinaryShares_c20251201__20260531_zdbnAXMHVbRa" title="PubCo class b ordinary shares"&gt;25,750,000&lt;/span&gt; PubCo Class B Ordinary Share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the New Merger Agreement, Eight Directions
agreed to provide Blue Jay Investment LLC, the sponsor of Quartzsea, a working capital loan of $&lt;span id="xdx_908_ecustom--WorkingCapitalLoans_iI_c20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zbatwQjjTgl7" title="Working capital loan"&gt;300,000&lt;/span&gt; in exchange for promissory note
issued by the sponsor. As of May 31, 2026, the Sponsor received $&lt;span id="xdx_90C_ecustom--TransactionExpenses_iI_c20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorReceivedMember_zXtQFnlBzpsi" title="Transaction expenses"&gt;200,000&lt;/span&gt; under such arrangement and has not funded Quartzsea&#x2019;s transaction
expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Additionally, Eight Directions is responsible
for funding all extension contributions required in connection with any extension of Quartzsea&#x2019;s deadline to consummate an initial
business combination. In accordance with such obligation, Eight Directions remits each applicable extension contribution to Quartzsea&#x2019;s
Trust Account, following which Quartzsea causes the applicable payment to be made in accordance with the Trust Agreement. The first extension
contribution of $&lt;span id="xdx_901_eus-gaap--Deposits_iI_c20260531_zfhUJeozRfz6" title="Deposits"&gt;175,000&lt;/span&gt; was funded by Eight Directions and deposited into the trust account on June 25, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Termination&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The New Merger Agreement contains customary
termination provisions and may be terminated by either party under specified circumstances, including by mutual written consent, the
failure to satisfy certain closing conditions, the occurrence of a material adverse effect, the failure to obtain required
regulatory approvals despite commercially reasonable efforts, specified delays in consummating the transaction, or an uncured
material breach by the other party following the applicable cure period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under certain circumstances involving an
uncured material breach by either party, the non-breaching party may be entitled to receive a termination fee of $&lt;span id="xdx_90A_ecustom--TerminationFee_c20251201__20260531_zbuNJ2kRkpah" title="Termination fee"&gt;500,000&lt;/span&gt;.
No termination fee is payable if the New Merger Agreement is terminated due to specified events outside the parties&#x2019;
reasonable control, including the failure to obtain required regulatory approvals despite commercially reasonable efforts or other
circumstances specified in the Merger Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Related Agreements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the execution of the New
Merger Agreement, the parties entered into the following related agreements:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Sponsor Support Agreement.&lt;/b&gt; The Sponsor and certain founder
shareholders agreed, among other things, to vote their shares in favor of the business combination, refrain from transferring or redeeming
their covered shares prior to the closing, and comply with certain customary covenants in support of the transaction. The Sponsor Support
Agreement terminates upon the earlier of the closing of the business combination or the termination of the Merger Agreement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 40px; text-indent: -20px; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Shareholder Support Agreements.&lt;/b&gt; Certain shareholders
of Eight Directions agreed to vote their shares in favor of the business combination and to be bound by certain customary covenants to
facilitate the completion of the transaction.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-left: 40px; text-indent: -20px; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Lock-Up Agreements.&lt;/b&gt; At the closing of the business combination,
certain Eight Directions shareholders are expected to enter into lock-up agreements restricting the transfer of specified PubCo ordinary
shares for 180 days following the closing, subject to customary exceptions and early release provisions specified in the agreements.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-left: 40px; text-indent: -20px; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Going Concern Consideration&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of May&#160;31, 2026, the Company had $&lt;span id="xdx_900_eus-gaap--Cash_iI_pp0p0_c20260531_zkcXecG2b1kg" title="Cash"&gt;5,156&lt;/span&gt;
of cash and a working capital deficit of $&lt;span id="xdx_90A_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20260531_zvyCO4M9JO13" title="Working capital deficit"&gt;1,035,078&lt;/span&gt;. The Company has incurred and expects to continue to incur significant
costs in pursuit of the consummation of an initial Business Combination.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to May 31, 2026, on June 23, 2026,
the Company&#x2019;s shareholders approved amendments to the Company&#x2019;s governing documents and Investment Management Trust Agreement
to extend the deadline to consummate an initial business combination from June 19, 2026 to October 19, 2026, with the ability to extend
such deadline on a month-to-month basis for up to four additional one-month periods. If the Company does not complete a business combination
within the prescribed timeline, it will be required to cease operations and liquidate in accordance with its Amended and Restated Memorandum
and Articles of Association.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with ASC 205-40, &lt;i&gt;Presentation
of Financial Statements&#x2014;Going Concern&lt;/i&gt;, management evaluated whether conditions and events raise substantial doubt about the
Company&#x2019;s ability to continue as a going concern within one year after the date the financial statements are issued. Management
concluded that, due to the Company&#x2019;s liquidity condition and requirement to complete a business combination within the prescribed
period to avoid liquidation, substantial doubt exists about the Company&#x2019;s ability to continue as a going concern. The financial
statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000432"
      unitRef="Shares">8280000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000434"
      unitRef="Shares">1080000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_IPOMember"
      decimals="0"
      id="Fact000436"
      unitRef="USD">82800000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000438"
      unitRef="Shares">231900</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-03-19_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000440"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000442"
      unitRef="USD">2319000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <CIK0002047455:TransactionCosts
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000444"
      unitRef="USD">4361752</CIK0002047455:TransactionCosts>
    <us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000446"
      unitRef="USD">3898500</us-gaap:ExpenseRelatedToDistributionOrServicingAndUnderwritingFees>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000448"
      unitRef="USD">586500</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000450"
      unitRef="USD">463252</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AssetsHeldInTrust
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000452"
      unitRef="USD">1245878</us-gaap:AssetsHeldInTrust>
    <us-gaap:SharePrice
      contextRef="AsOf2026-05-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000454"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <CIK0002047455:Deposit
      contextRef="AsOf2026-06-23"
      decimals="0"
      id="Fact000457"
      unitRef="USD">175000</CIK0002047455:Deposit>
    <CIK0002047455:OutstandingPublicShare
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000459"
      unitRef="USDPShares">0.033</CIK0002047455:OutstandingPublicShare>
    <CIK0002047455:ExtraordinaryGeneralMeeting
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000461"
      unitRef="Shares">1275382</CIK0002047455:ExtraordinaryGeneralMeeting>
    <CIK0002047455:AggregatePerShare
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000463"
      unitRef="USDPShares">10.50</CIK0002047455:AggregatePerShare>
    <CIK0002047455:PaymentRedemptionValue
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000465"
      unitRef="USD">13391956</CIK0002047455:PaymentRedemptionValue>
    <CIK0002047455:PaymentRedemptionShares
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000467"
      unitRef="Shares">10134518</CIK0002047455:PaymentRedemptionShares>
    <CIK0002047455:Deposit
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000469"
      unitRef="USD">73550934</CIK0002047455:Deposit>
    <us-gaap:SharePrice
      contextRef="AsOf2026-05-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000472"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <CIK0002047455:WorkingCapitalLoan
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000474"
      unitRef="USD">500000</CIK0002047455:WorkingCapitalLoan>
    <CIK0002047455:TransactionExpenses
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000476"
      unitRef="USD">500000</CIK0002047455:TransactionExpenses>
    <CIK0002047455:TransactionExpenses
      contextRef="AsOf2026-05-31_custom_SponsorMember"
      decimals="0"
      id="Fact000478"
      unitRef="USD">174000</CIK0002047455:TransactionExpenses>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-12-012026-05-31_custom_PubCoOrdinarySharesMember"
      decimals="0"
      id="Fact000481"
      unitRef="USD">515000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-12-012026-05-31_custom_PubCoOrdinarySharesMember"
      decimals="INF"
      id="Fact000483"
      unitRef="Shares">51500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <CIK0002047455:PubcoClassOrdinaryShares
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000485"
      unitRef="Shares">25750000</CIK0002047455:PubcoClassOrdinaryShares>
    <CIK0002047455:PubcoClassBOrdinaryShares
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000487"
      unitRef="Shares">25750000</CIK0002047455:PubcoClassBOrdinaryShares>
    <CIK0002047455:PubcoClassOrdinaryShares
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000489"
      unitRef="Shares">25750000</CIK0002047455:PubcoClassOrdinaryShares>
    <CIK0002047455:PubcoClassBOrdinaryShares
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000491"
      unitRef="Shares">25750000</CIK0002047455:PubcoClassBOrdinaryShares>
    <CIK0002047455:WorkingCapitalLoans
      contextRef="AsOf2026-05-31_custom_SponsorMember"
      decimals="0"
      id="Fact000493"
      unitRef="USD">300000</CIK0002047455:WorkingCapitalLoans>
    <CIK0002047455:TransactionExpenses
      contextRef="AsOf2026-05-31_custom_SponsorReceivedMember"
      decimals="0"
      id="Fact000495"
      unitRef="USD">200000</CIK0002047455:TransactionExpenses>
    <us-gaap:Deposits
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000497"
      unitRef="USD">175000</us-gaap:Deposits>
    <CIK0002047455:TerminationFee
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000499"
      unitRef="USD">500000</CIK0002047455:TerminationFee>
    <us-gaap:Cash
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000502"
      unitRef="USD">5156</us-gaap:Cash>
    <CIK0002047455:WorkingCapitalDeficit
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000504"
      unitRef="USD">1035078</CIK0002047455:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000506">&lt;p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zvsgrOi3iCd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2 &#x2014; &lt;span id="xdx_824_zdFVLPmqRwA8"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlnbhpcLA9sd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zzYEt0PUd4U3"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed
consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of
America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the
information and footnotes required by the U.S. GAAP. In the opinion of management, the unaudited condensed financial statements
reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and
results for the periods presented. They should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the
fiscal year ended November 30, 2025 filed with the SEC on March 16, 2026. The interim results for the three and six months ended
May&#160;31, 2026 are not necessarily indicative of the results that may be expected through November&#160;30, 2026 or for any
future periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zBVso3faaqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zERO5PNTM5Bb"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 

 
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_z51SyxDssMm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86D_zlz8kNOkCy4f"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In preparing these unaudited condensed financial statements in conformity with U.S. GAAP, the Company&#x2019;s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6PKcrMmcV0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zdDfpBaBLRG3"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $&lt;span id="xdx_904_eus-gaap--Cash_iI_pp0p0_c20260531_zLOUFS1VKSu6"&gt;5,156 &lt;/span&gt;and $&lt;span id="xdx_905_eus-gaap--Cash_pp0p0_c20251130_zumwmsw8d1V7"&gt;12,095 &lt;/span&gt;in cash and &lt;span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20260531_zyYKMzZH5rrb" title="Cash equivalents"&gt;&lt;span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20251130_zbV38juxi2c4" title="Cash equivalents"&gt;none&lt;/span&gt;&lt;/span&gt; in cash equivalents as of May&#160;31, 2026 and November&#160;30, 2025, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_845_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFGHCHSh4YN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_z8AHWewcCMe5"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of May&#160;31, 2026, substantially all
of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities.
All of the Company&#x2019;s investments held in the Trust Account are classified as trading securities. Trading securities are
presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair
value of investments held in the Trust Account are included in interest earned on investments held in Trust Account in the
accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available
market information. Fair values of these investments are determined by Level&#160;1 inputs utilizing quoted prices (unadjusted) in
active markets for identical assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zQOuzo774bv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zL9ozPOZdjFb"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20260531_znTteQXO1Hr7" title="FDIC Coverage limit"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such an account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbdP9tO39L5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_zqQom7iSi5o2"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zhiZYpHnxCR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zt7DYT1A40ig"&gt; Offering Costs&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, &#x201c;Other Assets and Deferred Costs &#x2013; SEC Materials&#x201d; (&#x201c;ASC 340-10-S99&#x201d;) and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering&#x201d;. Deferred offering costs were $&lt;span id="xdx_905_eus-gaap--DeferredCostsCurrent_iI_c20260531_ziwXqnrT7nr6" title="Deferred offering costs"&gt;4,361,752&lt;/span&gt; consisting principally of $&lt;span id="xdx_905_eus-gaap--OtherUnderwritingExpense_c20251201__20260531_ztIouXY30TB8" title="Underwriting fees"&gt;3,898,500&lt;/span&gt; underwriting fees and $&lt;span id="xdx_901_eus-gaap--LegalFees_c20251201__20260531_zw2HNmXcJlTi" title="Legal and other expenses"&gt;463,252&lt;/span&gt; legal and other expenses that were directly related to the IPO. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Rights and Private Placement Units were charged to shareholders&#x2019; equity based on the classification of underlying financial instruments upon the completion of the IPO.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 

 

&lt;p id="xdx_84D_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zABrnKeWoNs5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_z15jTaOXDOyj"&gt;Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (ASC 480). Ordinary shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as shareholders&#x2019; equity. In accordance with ASC 480-10-S99, the Company classifies the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251201__20260531__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zh90Fnro0NV7" title="Number of shares issued"&gt;8,280,000&lt;/span&gt; ordinary shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The initial accretion and subsequent remeasurements will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). Accordingly, as of May&#160;31, 2026, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of May&#160;31, 2026, the ordinary shares subject to redemption reflected in the balance sheet are reconciled in the following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--TemporaryEquityTableTextBlock_zojMwgNoeOXh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8BD_zz97ezIIolH7" style="display: none"&gt;Schedule of ordinary shares subject to redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"&gt;Gross proceeds from IPO&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iS_c20250601__20251130_zqedsBTOiHre" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iS_c20250601__20251130_z2j2OuFKCTL2" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;82,800,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Less:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ProceedsAllocatedToPublicRights_c20250601__20251130_zaZYWOOEHEXc" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(1,904,400&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AllocationOfOfferingCostsRelatedToRedeemableShares_c20250601__20251130_z4ui9vUOayw6" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(4,261,431&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Plus:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfCarryingValueToRedemptionsValue_c20250601__20251130_zvkheG2TVvYb" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value"&gt;8,568,563&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Ordinary shares subject to possible redemption &#x96; November 30, 2025&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iS_c20251201__20260531_zfvzncodxeb3" style="text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iS_c20251201__20260531_zkWDXjSPLmQg" style="text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;85,202,732&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Plus:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfCarryingValueToRedemptionsValue_c20251201__20260531_zuWO7eVPMw9b" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value"&gt;1,530,146&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Ordinary shares subject to possible redemption &#x2013; May&#160;31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iE_c20251201__20260531_ziKDzcQWLkv1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iE_c20251201__20260531_zed2VubUPQ6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;86,732,878&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zdRcw4Hb2ZNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zxv5B5vxs4cf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_zmdkUX6DNlbk"&gt;Net Income (Loss) Per Ordinary Share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The unaudited condensed statements of operations include a presentation of net income (loss) per redeemable share and net income (loss) per non-redeemable share following the two-class method of net income per share because redemption of the redeemable shares is not at fair value pursuant to the guidance in ASC 480-10-S99. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has elected to treat only the portion of the periodic adjustment to the carrying amount of the redeemable shares that reflects a redemption in excess of fair value like a dividend. As such, income or loss allocable to each class of ordinary share is not adjusted for the accretion of carrying value to redemption value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The calculation of diluted net income per ordinary share does not consider the effect of the rights issued in connection with the IPO and the Private Units since the exercise of the rights is contingent upon the occurrence of future events. As of May&#160;31,  2026, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares that then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented.&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The net income (loss) per share presented in the
unaudited condensed consolidated statements of operations is based on the following:&lt;/p&gt; 

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfCondensedConsolidatedStatementsOfOperationsTableTextBlock_zLOOjusOk3Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B2_z0zxSPojZQb4" style="display: none"&gt;Schedule of statement of operation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260301__20260531_zKi2GTq4vuCb" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250301__20250531_zwYONEsf6wi2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20251201__20260531_zVxg8oj2dEw1" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241201__20250531_zMTZVKoO7NY7" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLoss_z9VtWXjla4F2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;573,672&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(27,147&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;1,102,757&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(58,402&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

 

&lt;p id="xdx_8A1_zugj5JXlnwpi" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zR2IdKfnT9Sa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span id="xdx_8B5_zCcjm5H2WdA2" style="display: none"&gt;Schedule of net income per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zp9LBRo5gTpf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zwiRIFhNFTXg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zQzdvTwRCtfa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYO1n9nNWZZ8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;br/&gt;
May&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;br/&gt;
 May&#160;31,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Non-redeemable&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Ordinary&lt;br/&gt;
Shares&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zwgFLerzoD1k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income (loss)
    per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NumeratorAbstract_iB_zvEopNQ72sG4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zghhXMz4be3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Allocation
    of net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;416,306&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;157,366&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(18,629&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(8,518&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DenominatorAbstract_iB_zQAU11ZMgZ5d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z7UvSGTOao1i" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zwFpG6izBeNb" title="Basic and diluted weighted average shares outstanding"&gt;8,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zb0I74kNHnUa" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrLOMMcU4Slc" title="Basic and diluted weighted average shares outstanding"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zpJzH5Cr52ak" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zwd7wZd8Fbg4" title="Basic and diluted weighted average shares outstanding"&gt;6,570,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zfzzZaXL1ub2" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zINiOgLC7ns1" title="Basic and diluted weighted average shares outstanding"&gt;3,003,942&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and
    diluted net income (loss) per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zNliY8Oeaep6" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zdgTAj5O1wwa" title="Basic and diluted net income per share"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zjPQtxBAfzGk" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zrygiq3QFA69" title="Basic and diluted net income per share"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_znQJ4uRABGti" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zabwiOdshWg6" title="Basic and diluted net income per share"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zESHEl4Ic2Yj" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareDiluted_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zebA3lMCfSXe" title="Basic and diluted net income per share"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zuFz8478pJIk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zwzKPRK5Aan9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zFfQSDauBNHh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zyYS0RSZcAwf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;br/&gt; May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;br/&gt; May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zjTU1aLfXIa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income (loss)
    per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NumeratorAbstract_iB_zGVsiSDSRlGc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z5C5dqCoWOc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Allocation
    of net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;800,255&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;302,502&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(31,871&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(26,531&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DenominatorAbstract_iB_zxxs8ZDW9lBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z5mivGACUbmg" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zjWgbKT7W72i" title="Basic and diluted weighted average shares outstanding"&gt;8,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqXNHa96uJ5" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z3evrCoquS47" title="Basic and diluted weighted average shares outstanding"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zopwV2vW36Ma" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zJ3Ac1moKvkh" title="Basic and diluted weighted average shares outstanding"&gt;3,321,099&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMsadTXOgmsb" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zEge481r9ic2" title="Basic and diluted weighted average shares outstanding"&gt;2,764,630&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and
    diluted net income (loss) per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z6zH1owp1pc1" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zbEBxDGYbl2" title="Basic and diluted net income per share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zEE8Fzeq5fi2" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_z7e02yqM6NMf" title="Basic and diluted net income per share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zeIRH4sQOBhc" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zf5jycBmYNW7" title="Basic and diluted net income per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zACdzDDDZ1L6" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_z4NJlnRxV2Bd" title="Basic and diluted net income per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p id="xdx_8AE_zmhEd77yidge" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_84C_eus-gaap--LegalCostsPolicyTextBlock_zWEHESAR6cl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_z4Q8Vc00xFY3"&gt;Rights Accounting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for rights as either equity-classified or liability-classified instruments based on an assessment of the right&#x2019;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the rights are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the rights meet all of the requirements for equity classification under ASC 815, including whether the rights are indexed to the Company&#x2019;s own ordinary shares and whether the right holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of right issuance and as of each subsequent quarterly period end date while the rights are outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For issued or modified rights that meet all of the criteria for equity classification, the rights are required to be recorded as a component of equity at the time of issuance. For issued or modified rights that do not meet all the criteria for equity classification, the rights are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the rights are recognized as a non-cash gain or loss on the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The rights issued upon the closing of the IPO
and sale of Private Placement Units met the criteria for equity classification under ASC 815 and, accordingly, were classified as equity.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zfHnqpo3U9T9"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;). ASC 740, &#x201c;Income Taxes&#x201d;, requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the new law. However, none of the tax provisions are expected to have a significant impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes under ASC 740, which requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company&#x2019;s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of May&#160;31,  2026. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z5K3YOr1Lre5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zrXcGuS3Hp3i"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000508">&lt;p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zlnbhpcLA9sd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_zzYEt0PUd4U3"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed
consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of
America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the
information and footnotes required by the U.S. GAAP. In the opinion of management, the unaudited condensed financial statements
reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and
results for the periods presented. They should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the
fiscal year ended November 30, 2025 filed with the SEC on March 16, 2026. The interim results for the three and six months ended
May&#160;31, 2026 are not necessarily indicative of the results that may be expected through November&#160;30, 2026 or for any
future periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <CIK0002047455:EmergingGrowthCompanyPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000510">&lt;p id="xdx_841_ecustom--EmergingGrowthCompanyPolicyTextBlock_zBVso3faaqz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zERO5PNTM5Bb"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 

 
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
</CIK0002047455:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2025-12-01to2026-05-31" id="Fact000513">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_z51SyxDssMm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86D_zlz8kNOkCy4f"&gt;Use of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In preparing these unaudited condensed financial statements in conformity with U.S. GAAP, the Company&#x2019;s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000515">&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6PKcrMmcV0g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86A_zdDfpBaBLRG3"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $&lt;span id="xdx_904_eus-gaap--Cash_iI_pp0p0_c20260531_zLOUFS1VKSu6"&gt;5,156 &lt;/span&gt;and $&lt;span id="xdx_905_eus-gaap--Cash_pp0p0_c20251130_zumwmsw8d1V7"&gt;12,095 &lt;/span&gt;in cash and &lt;span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20260531_zyYKMzZH5rrb" title="Cash equivalents"&gt;&lt;span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_dn_c20251130_zbV38juxi2c4" title="Cash equivalents"&gt;none&lt;/span&gt;&lt;/span&gt; in cash equivalents as of May&#160;31, 2026 and November&#160;30, 2025, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000516"
      unitRef="USD">5156</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000517"
      unitRef="USD">12095</us-gaap:Cash>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000519"
      unitRef="USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000521"
      unitRef="USD">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <CIK0002047455:InvestmentsHeldInTrustAccountPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000523">&lt;p id="xdx_845_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zFGHCHSh4YN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_860_z8AHWewcCMe5"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of May&#160;31, 2026, substantially all
of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury securities.
All of the Company&#x2019;s investments held in the Trust Account are classified as trading securities. Trading securities are
presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair
value of investments held in the Trust Account are included in interest earned on investments held in Trust Account in the
accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available
market information. Fair values of these investments are determined by Level&#160;1 inputs utilizing quoted prices (unadjusted) in
active markets for identical assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</CIK0002047455:InvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-12-01to2026-05-31" id="Fact000525">&lt;p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zQOuzo774bv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zL9ozPOZdjFb"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $&lt;span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20260531_znTteQXO1Hr7" title="FDIC Coverage limit"&gt;250,000&lt;/span&gt;. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such an account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000527"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-12-01to2026-05-31" id="Fact000529">&lt;p id="xdx_844_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zbdP9tO39L5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_zqQom7iSi5o2"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, &#x201c;Fair Value Measurement,&#x201d; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <CIK0002047455:OfferingCostsPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000531">&lt;p id="xdx_841_ecustom--OfferingCostsPolicyTextBlock_zhiZYpHnxCR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zt7DYT1A40ig"&gt; Offering Costs&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, &#x201c;Other Assets and Deferred Costs &#x2013; SEC Materials&#x201d; (&#x201c;ASC 340-10-S99&#x201d;) and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering&#x201d;. Deferred offering costs were $&lt;span id="xdx_905_eus-gaap--DeferredCostsCurrent_iI_c20260531_ziwXqnrT7nr6" title="Deferred offering costs"&gt;4,361,752&lt;/span&gt; consisting principally of $&lt;span id="xdx_905_eus-gaap--OtherUnderwritingExpense_c20251201__20260531_ztIouXY30TB8" title="Underwriting fees"&gt;3,898,500&lt;/span&gt; underwriting fees and $&lt;span id="xdx_901_eus-gaap--LegalFees_c20251201__20260531_zw2HNmXcJlTi" title="Legal and other expenses"&gt;463,252&lt;/span&gt; legal and other expenses that were directly related to the IPO. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Rights and Private Placement Units were charged to shareholders&#x2019; equity based on the classification of underlying financial instruments upon the completion of the IPO.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 

 

</CIK0002047455:OfferingCostsPolicyTextBlock>
    <us-gaap:DeferredCostsCurrent
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000533"
      unitRef="USD">4361752</us-gaap:DeferredCostsCurrent>
    <us-gaap:OtherUnderwritingExpense
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000535"
      unitRef="USD">3898500</us-gaap:OtherUnderwritingExpense>
    <us-gaap:LegalFees
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000537"
      unitRef="USD">463252</us-gaap:LegalFees>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000540">&lt;p id="xdx_84D_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zABrnKeWoNs5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86C_z15jTaOXDOyj"&gt;Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (ASC 480). Ordinary shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as shareholders&#x2019; equity. In accordance with ASC 480-10-S99, the Company classifies the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20251201__20260531__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesMember_zh90Fnro0NV7" title="Number of shares issued"&gt;8,280,000&lt;/span&gt; ordinary shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The initial accretion and subsequent remeasurements will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). Accordingly, as of May&#160;31, 2026, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of May&#160;31, 2026, the ordinary shares subject to redemption reflected in the balance sheet are reconciled in the following table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--TemporaryEquityTableTextBlock_zojMwgNoeOXh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8BD_zz97ezIIolH7" style="display: none"&gt;Schedule of ordinary shares subject to redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"&gt;Gross proceeds from IPO&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iS_c20250601__20251130_zqedsBTOiHre" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iS_c20250601__20251130_z2j2OuFKCTL2" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;82,800,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Less:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ProceedsAllocatedToPublicRights_c20250601__20251130_zaZYWOOEHEXc" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(1,904,400&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AllocationOfOfferingCostsRelatedToRedeemableShares_c20250601__20251130_z4ui9vUOayw6" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(4,261,431&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Plus:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfCarryingValueToRedemptionsValue_c20250601__20251130_zvkheG2TVvYb" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value"&gt;8,568,563&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Ordinary shares subject to possible redemption &#x96; November 30, 2025&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iS_c20251201__20260531_zfvzncodxeb3" style="text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iS_c20251201__20260531_zkWDXjSPLmQg" style="text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;85,202,732&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Plus:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfCarryingValueToRedemptionsValue_c20251201__20260531_zuWO7eVPMw9b" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value"&gt;1,530,146&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Ordinary shares subject to possible redemption &#x2013; May&#160;31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iE_c20251201__20260531_ziKDzcQWLkv1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iE_c20251201__20260531_zed2VubUPQ6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;86,732,878&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zdRcw4Hb2ZNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-12-012026-05-31_custom_OrdinarySharesMember"
      decimals="INF"
      id="Fact000542"
      unitRef="Shares">8280000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000544">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--TemporaryEquityTableTextBlock_zojMwgNoeOXh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;&lt;span id="xdx_8BD_zz97ezIIolH7" style="display: none"&gt;Schedule of ordinary shares subject to redemption&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left"&gt;Gross proceeds from IPO&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iS_c20250601__20251130_zqedsBTOiHre" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iS_c20250601__20251130_z2j2OuFKCTL2" style="width: 9%; text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;82,800,000&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Less:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Proceeds allocated to Public Rights&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ProceedsAllocatedToPublicRights_c20250601__20251130_zaZYWOOEHEXc" style="text-align: right" title="Proceeds allocated to Public Rights"&gt;(1,904,400&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Allocation of offering costs related to redeemable shares&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AllocationOfOfferingCostsRelatedToRedeemableShares_c20250601__20251130_z4ui9vUOayw6" style="text-align: right" title="Allocation of offering costs related to redeemable shares"&gt;(4,261,431&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Plus:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfCarryingValueToRedemptionsValue_c20250601__20251130_zvkheG2TVvYb" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value"&gt;8,568,563&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Ordinary shares subject to possible redemption &#x96; November 30, 2025&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iS_c20251201__20260531_zfvzncodxeb3" style="text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iS_c20251201__20260531_zkWDXjSPLmQg" style="text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;85,202,732&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Plus:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"&gt;Remeasurement of carrying value to redemption value&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;-&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RemeasurementOfCarryingValueToRedemptionsValue_c20251201__20260531_zuWO7eVPMw9b" style="border-bottom: Black 1pt solid; text-align: right" title="Remeasurement of carrying value to redemption value"&gt;1,530,146&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Ordinary shares subject to possible redemption &#x2013; May&#160;31, 2026&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OrdinarySharesSubjectToPossibleRedemptionShares_iE_c20251201__20260531_ziKDzcQWLkv1" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, shares"&gt;8,280,000&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OrdinarySharesSubjectToPossibleRedemptionAmount_iE_c20251201__20260531_zed2VubUPQ6d" style="border-bottom: Black 2.5pt double; text-align: right" title="Ordinary shares subject to possible redemption, amount"&gt;86,732,878&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:TemporaryEquityTableTextBlock>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionShares
      contextRef="AsOf2025-05-31"
      decimals="INF"
      id="Fact000546"
      unitRef="Shares">8280000</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionShares>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionAmount
      contextRef="AsOf2025-05-31"
      decimals="0"
      id="Fact000548"
      unitRef="USD">82800000</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionAmount>
    <CIK0002047455:ProceedsAllocatedToPublicRights
      contextRef="From2025-06-012025-11-30"
      decimals="0"
      id="Fact000550"
      unitRef="USD">-1904400</CIK0002047455:ProceedsAllocatedToPublicRights>
    <CIK0002047455:AllocationOfOfferingCostsRelatedToRedeemableShares
      contextRef="From2025-06-012025-11-30"
      decimals="0"
      id="Fact000552"
      unitRef="USD">-4261431</CIK0002047455:AllocationOfOfferingCostsRelatedToRedeemableShares>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionsValue
      contextRef="From2025-06-012025-11-30"
      decimals="0"
      id="Fact000554"
      unitRef="USD">8568563</CIK0002047455:RemeasurementOfCarryingValueToRedemptionsValue>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionShares
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000556"
      unitRef="Shares">8280000</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionShares>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionAmount
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000558"
      unitRef="USD">85202732</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionAmount>
    <CIK0002047455:RemeasurementOfCarryingValueToRedemptionsValue
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000560"
      unitRef="USD">1530146</CIK0002047455:RemeasurementOfCarryingValueToRedemptionsValue>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionShares
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000562"
      unitRef="Shares">8280000</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionShares>
    <CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionAmount
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000564"
      unitRef="USD">86732878</CIK0002047455:OrdinarySharesSubjectToPossibleRedemptionAmount>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000566">&lt;p id="xdx_845_eus-gaap--EarningsPerSharePolicyTextBlock_zxv5B5vxs4cf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_863_zmdkUX6DNlbk"&gt;Net Income (Loss) Per Ordinary Share&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The unaudited condensed statements of operations include a presentation of net income (loss) per redeemable share and net income (loss) per non-redeemable share following the two-class method of net income per share because redemption of the redeemable shares is not at fair value pursuant to the guidance in ASC 480-10-S99. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has elected to treat only the portion of the periodic adjustment to the carrying amount of the redeemable shares that reflects a redemption in excess of fair value like a dividend. As such, income or loss allocable to each class of ordinary share is not adjusted for the accretion of carrying value to redemption value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The calculation of diluted net income per ordinary share does not consider the effect of the rights issued in connection with the IPO and the Private Units since the exercise of the rights is contingent upon the occurrence of future events. As of May&#160;31,  2026, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares that then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented.&lt;/p&gt; 

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The net income (loss) per share presented in the
unaudited condensed consolidated statements of operations is based on the following:&lt;/p&gt; 

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfCondensedConsolidatedStatementsOfOperationsTableTextBlock_zLOOjusOk3Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B2_z0zxSPojZQb4" style="display: none"&gt;Schedule of statement of operation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260301__20260531_zKi2GTq4vuCb" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250301__20250531_zwYONEsf6wi2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20251201__20260531_zVxg8oj2dEw1" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241201__20250531_zMTZVKoO7NY7" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLoss_z9VtWXjla4F2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;573,672&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(27,147&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;1,102,757&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(58,402&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

 

&lt;p id="xdx_8A1_zugj5JXlnwpi" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zR2IdKfnT9Sa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span id="xdx_8B5_zCcjm5H2WdA2" style="display: none"&gt;Schedule of net income per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zp9LBRo5gTpf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zwiRIFhNFTXg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zQzdvTwRCtfa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYO1n9nNWZZ8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;br/&gt;
May&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;br/&gt;
 May&#160;31,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Non-redeemable&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Ordinary&lt;br/&gt;
Shares&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zwgFLerzoD1k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income (loss)
    per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NumeratorAbstract_iB_zvEopNQ72sG4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zghhXMz4be3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Allocation
    of net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;416,306&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;157,366&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(18,629&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(8,518&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DenominatorAbstract_iB_zQAU11ZMgZ5d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z7UvSGTOao1i" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zwFpG6izBeNb" title="Basic and diluted weighted average shares outstanding"&gt;8,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zb0I74kNHnUa" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrLOMMcU4Slc" title="Basic and diluted weighted average shares outstanding"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zpJzH5Cr52ak" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zwd7wZd8Fbg4" title="Basic and diluted weighted average shares outstanding"&gt;6,570,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zfzzZaXL1ub2" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zINiOgLC7ns1" title="Basic and diluted weighted average shares outstanding"&gt;3,003,942&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and
    diluted net income (loss) per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zNliY8Oeaep6" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zdgTAj5O1wwa" title="Basic and diluted net income per share"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zjPQtxBAfzGk" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zrygiq3QFA69" title="Basic and diluted net income per share"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_znQJ4uRABGti" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zabwiOdshWg6" title="Basic and diluted net income per share"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zESHEl4Ic2Yj" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareDiluted_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zebA3lMCfSXe" title="Basic and diluted net income per share"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zuFz8478pJIk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zwzKPRK5Aan9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zFfQSDauBNHh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zyYS0RSZcAwf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;br/&gt; May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;br/&gt; May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zjTU1aLfXIa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income (loss)
    per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NumeratorAbstract_iB_zGVsiSDSRlGc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z5C5dqCoWOc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Allocation
    of net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;800,255&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;302,502&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(31,871&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(26,531&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DenominatorAbstract_iB_zxxs8ZDW9lBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z5mivGACUbmg" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zjWgbKT7W72i" title="Basic and diluted weighted average shares outstanding"&gt;8,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqXNHa96uJ5" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z3evrCoquS47" title="Basic and diluted weighted average shares outstanding"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zopwV2vW36Ma" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zJ3Ac1moKvkh" title="Basic and diluted weighted average shares outstanding"&gt;3,321,099&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMsadTXOgmsb" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zEge481r9ic2" title="Basic and diluted weighted average shares outstanding"&gt;2,764,630&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and
    diluted net income (loss) per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z6zH1owp1pc1" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zbEBxDGYbl2" title="Basic and diluted net income per share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zEE8Fzeq5fi2" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_z7e02yqM6NMf" title="Basic and diluted net income per share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zeIRH4sQOBhc" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zf5jycBmYNW7" title="Basic and diluted net income per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zACdzDDDZ1L6" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_z4NJlnRxV2Bd" title="Basic and diluted net income per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





&lt;p id="xdx_8AE_zmhEd77yidge" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:EarningsPerSharePolicyTextBlock>
    <CIK0002047455:ScheduleOfCondensedConsolidatedStatementsOfOperationsTableTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000569">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfCondensedConsolidatedStatementsOfOperationsTableTextBlock_zLOOjusOk3Wh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B2_z0zxSPojZQb4" style="display: none"&gt;Schedule of statement of operation&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260301__20260531_zKi2GTq4vuCb" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250301__20250531_zwYONEsf6wi2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20251201__20260531_zVxg8oj2dEw1" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20241201__20250531_zMTZVKoO7NY7" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLoss_z9VtWXjla4F2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;573,672&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(27,147&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;1,102,757&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(58,402&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

 

</CIK0002047455:ScheduleOfCondensedConsolidatedStatementsOfOperationsTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000571"
      unitRef="USD">573672</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000572"
      unitRef="USD">-27147</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000573"
      unitRef="USD">1102757</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000574"
      unitRef="USD">-58402</us-gaap:NetIncomeLoss>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000576">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zR2IdKfnT9Sa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&lt;span id="xdx_8B5_zCcjm5H2WdA2" style="display: none"&gt;Schedule of net income per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zp9LBRo5gTpf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zwiRIFhNFTXg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zQzdvTwRCtfa" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zYO1n9nNWZZ8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;br/&gt;
May&#160;31,&lt;br/&gt;
2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;br/&gt;
 May&#160;31,&lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Non-redeemable&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Ordinary&lt;br/&gt;
Shares&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zwgFLerzoD1k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income (loss)
    per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NumeratorAbstract_iB_zvEopNQ72sG4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zghhXMz4be3d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Allocation
    of net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;416,306&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;157,366&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(18,629&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(8,518&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DenominatorAbstract_iB_zQAU11ZMgZ5d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z7UvSGTOao1i" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zwFpG6izBeNb" title="Basic and diluted weighted average shares outstanding"&gt;8,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zb0I74kNHnUa" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zrLOMMcU4Slc" title="Basic and diluted weighted average shares outstanding"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zpJzH5Cr52ak" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zwd7wZd8Fbg4" title="Basic and diluted weighted average shares outstanding"&gt;6,570,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zfzzZaXL1ub2" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zINiOgLC7ns1" title="Basic and diluted weighted average shares outstanding"&gt;3,003,942&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and
    diluted net income (loss) per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zNliY8Oeaep6" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zdgTAj5O1wwa" title="Basic and diluted net income per share"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareBasic_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zjPQtxBAfzGk" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_c20260301__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zrygiq3QFA69" title="Basic and diluted net income per share"&gt;0.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_znQJ4uRABGti" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_902_eus-gaap--EarningsPerShareDiluted_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zabwiOdshWg6" title="Basic and diluted net income per share"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zESHEl4Ic2Yj" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_900_eus-gaap--EarningsPerShareDiluted_c20250301__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zebA3lMCfSXe" title="Basic and diluted net income per share"&gt;(0.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Significant Accounting Policies (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zuFz8478pJIk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zwzKPRK5Aan9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zFfQSDauBNHh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zyYS0RSZcAwf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;br/&gt; May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2026&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months Ended&lt;br/&gt; May&#160;31,&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Redeemable&lt;br/&gt;
Ordinary&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-redeemable&lt;br/&gt;
Ordinary&lt;br/&gt;
Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BasicAndDilutedNetPerShareAbstract_iB_zjTU1aLfXIa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income (loss)
    per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--NumeratorAbstract_iB_zGVsiSDSRlGc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_z5C5dqCoWOc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left; padding-bottom: 2.5pt"&gt;Allocation
    of net income (loss)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;800,255&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;302,502&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(31,871&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 9%; text-align: right"&gt;(26,531&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DenominatorAbstract_iB_zxxs8ZDW9lBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in; padding-bottom: 2.5pt; vertical-align: top"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z5mivGACUbmg" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zjWgbKT7W72i" title="Basic and diluted weighted average shares outstanding"&gt;8,280,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zqXNHa96uJ5" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_z3evrCoquS47" title="Basic and diluted weighted average shares outstanding"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zopwV2vW36Ma" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zJ3Ac1moKvkh" title="Basic and diluted weighted average shares outstanding"&gt;3,321,099&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zMsadTXOgmsb" title="Basic and diluted weighted average shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableSharesMember_zEge481r9ic2" title="Basic and diluted weighted average shares outstanding"&gt;2,764,630&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"&gt;Basic and
    diluted net income (loss) per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_z6zH1owp1pc1" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareDiluted_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zbEBxDGYbl2" title="Basic and diluted net income per share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zEE8Fzeq5fi2" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareDiluted_c20251201__20260531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_z7e02yqM6NMf" title="Basic and diluted net income per share"&gt;0.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zeIRH4sQOBhc" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--RedeemablesSharesMember_zf5jycBmYNW7" title="Basic and diluted net income per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_zACdzDDDZ1L6" title="Basic and diluted net income per share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20241201__20250531__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableClassAOrdinaryShareMember_z4NJlnRxV2Bd" title="Basic and diluted net income per share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;





</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2026-03-012026-05-31_custom_RedeemablesSharesMember"
      decimals="0"
      id="Fact000588"
      unitRef="USD">416306</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000589"
      unitRef="USD">157366</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-03-012025-05-31_custom_RedeemablesSharesMember"
      decimals="0"
      id="Fact000590"
      unitRef="USD">-18629</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000591"
      unitRef="USD">-8518</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-03-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000598"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-03-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000600"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000602"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000604"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-03-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000606"
      unitRef="Shares">6570000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-03-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000608"
      unitRef="Shares">6570000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000610"
      unitRef="Shares">3003942</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000612"
      unitRef="Shares">3003942</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-03-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000614"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-03-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000616"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000618"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2026-03-012026-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000620"
      unitRef="USDPShares">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-03-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000622"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-03-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000624"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000626"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-03-012025-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000628"
      unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-12-012026-05-31_custom_RedeemablesSharesMember"
      decimals="0"
      id="Fact000640"
      unitRef="USD">800255</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000641"
      unitRef="USD">302502</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-12-012025-05-31_custom_RedeemablesSharesMember"
      decimals="0"
      id="Fact000642"
      unitRef="USD">-31871</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="0"
      id="Fact000643"
      unitRef="USD">-26531</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-12-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000650"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-12-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000652"
      unitRef="Shares">8280000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000654"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000656"
      unitRef="Shares">3129900</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-12-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000658"
      unitRef="Shares">3321099</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-12-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000660"
      unitRef="Shares">3321099</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000662"
      unitRef="Shares">2764630</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableSharesMember"
      decimals="INF"
      id="Fact000664"
      unitRef="Shares">2764630</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-12-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000666"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-12-012026-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000668"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000670"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-12-012026-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000672"
      unitRef="USDPShares">0.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-12-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000674"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-12-012025-05-31_custom_RedeemablesSharesMember"
      decimals="INF"
      id="Fact000676"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000678"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-12-012025-05-31_custom_NonRedeemableClassAOrdinaryShareMember"
      decimals="INF"
      id="Fact000680"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:LegalCostsPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000682">&lt;p id="xdx_84C_eus-gaap--LegalCostsPolicyTextBlock_zWEHESAR6cl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_z4Q8Vc00xFY3"&gt;Rights Accounting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for rights as either equity-classified or liability-classified instruments based on an assessment of the right&#x2019;s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the rights are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the rights meet all of the requirements for equity classification under ASC 815, including whether the rights are indexed to the Company&#x2019;s own ordinary shares and whether the right holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of right issuance and as of each subsequent quarterly period end date while the rights are outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For issued or modified rights that meet all of the criteria for equity classification, the rights are required to be recorded as a component of equity at the time of issuance. For issued or modified rights that do not meet all the criteria for equity classification, the rights are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the rights are recognized as a non-cash gain or loss on the statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The rights issued upon the closing of the IPO
and sale of Private Placement Units met the criteria for equity classification under ASC 815 and, accordingly, were classified as equity.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_866_zfHnqpo3U9T9"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;). ASC 740, &#x201c;Income Taxes&#x201d;, requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the new law. However, none of the tax provisions are expected to have a significant impact on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for income taxes under ASC 740, which requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company&#x2019;s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of May&#160;31,  2026. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000685">&lt;p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z5K3YOr1Lre5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_zrXcGuS3Hp3i"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <CIK0002047455:InitialPublicOfferingTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000687">&lt;p id="xdx_801_ecustom--InitialPublicOfferingTextBlock_zL5mZb3ajJ29" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3 &#x2014; &lt;span id="xdx_82E_ziYHkhTlBCwb"&gt;Initial Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March&#160;19, 2025, the Company sold &lt;span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zIXitM9KU936" title="Sale of units in initial public offering"&gt;8,280,000&lt;/span&gt; Units (including full over-allotment of &lt;span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zM2G5sXuCOz5" title="Sale of units in initial public offering"&gt;1,080,000&lt;/span&gt; units), at a price of $&lt;span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_c20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zUUU6G1pchD9" title="Sale of units per share"&gt;10.00&lt;/span&gt; per Unit. Each Unit consists of one ordinary share, par value $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z8AEriOoCJAe" title="Warrant exercisable"&gt;0.0001&lt;/span&gt; per share and one right (the &#x201c;Public Right&#x201d;). Each Public Right entitles the holder to purchase one-fifth (1/5) of one ordinary share upon the consummation of the Company&#x2019;s initial Business Combination. The Company will not issue fractional shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

 

 

</CIK0002047455:InitialPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000689"
      unitRef="Shares">8280000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000691"
      unitRef="Shares">1080000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-03-19_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000693"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-03-19_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000695"
      unitRef="USDPShares">0.0001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <CIK0002047455:PrivatePlacementTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000698">&lt;p id="xdx_800_ecustom--PrivatePlacementTextBlock_zhlMHdRSwZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &#x2014; &lt;span&gt;&lt;span id="xdx_823_z5678bj4EbJ3"&gt;Private Placement&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zCBJM49iBIh7"&gt;231,900&lt;/span&gt; Private Units at a price of $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z3jmc82YJ8ci"&gt;10.00&lt;/span&gt; per Private Unit for an aggregate purchase price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pp0d_c20250301__20250319__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z1KueMDzsvf"&gt;2,319,000&lt;/span&gt;. Each Private Unit was identical to the Public Units sold in the IPO, except that they are not registered under the Securities Act. Additionally, the Sponsor has agreed not to transfer, assign, or sell any of the private units or the securities underlying such private units at least 30 days following the consummation of our business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Each Private Unit consists of one ordinary share (&#x201c;Private Share&#x201d;) and one right (&#x201c;Private Right&#x201d;). Each Private Right will convert into one-fifth (1/5) of one ordinary share upon the consummation of a Business Combination. The proceeds from the Private Units were added to the proceeds from the IPO which were deposited in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Units and all underlying securities will expire worthless.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</CIK0002047455:PrivatePlacementTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000699"
      unitRef="Shares">231900</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-03-19_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000700"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2025-03-012025-03-19_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000701"
      unitRef="USD">2319000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000703">&lt;p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zlEQoW1yR5bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5 &#x2014; &lt;span id="xdx_825_zk0ZP4xOvj7f"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November&#160;5, 2024, the Company issued to the Sponsor &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241101__20241105__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zpxRpaCDDG01" title="Aggregate of shares"&gt;1,725,000&lt;/span&gt; ordinary shares for an aggregated consideration of $&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20241101__20241105__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zD990JtPr4s" title="Aggregate value of shares"&gt;25,000&lt;/span&gt;, or approximately $&lt;span id="xdx_90E_eus-gaap--SharePrice_iI_c20241105__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zV39FnnBrIke" title="Share Price"&gt;0.0145&lt;/span&gt; per ordinary share. On February&#160;12, 2025, the Company and the Sponsor entered into the First Amendment to the Subscription Agreement, pursuant to which the purchased amount of shares was adjusted to &lt;span id="xdx_90F_eus-gaap--ConversionOfStockSharesConverted1_c20250203__20250212__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zucRohFVazia" title="Converted common shares"&gt;2,415,000&lt;/span&gt; ordinary shares, $&lt;span id="xdx_90A_eus-gaap--SharePrice_iI_c20250212__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_zsWFU1p2wEr9" title="Share Price"&gt;0.0104&lt;/span&gt; per ordinary share. On March&#160;17, 2025, the Company and the Sponsor entered into the Second Amendment to the Subscription Agreement, pursuant to which the purchased amount of Founder Shares was adjusted to &lt;span id="xdx_909_ecustom--AdjustedFounderShares_c20250301__20250317_zevezSjr1Mad" title="Adjusted Founder shares"&gt;2,898,000&lt;/span&gt;, of which &lt;span id="xdx_907_ecustom--SharesSubjectToForfeiture_c20250301__20250317__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderMember_zCLJk8j7OIN5" title="Shares subject to forfeiture"&gt;378,000&lt;/span&gt; are subject to forfeiture. As a result of the underwriter&#x2019;s full exercise of its over-allotment option on March&#160;19, 2025, no shares are subject to forfeiture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Initial Shareholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Founder Shares for a time period ending on the date that is the earlier of (A) six months after the completion of the Company&#x2019;s initial business combination or (B) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after its initial business combination that results in all of the public shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property. The Initial Shareholders also agree not to transfer any ownership interest in, except to permitted transferees, their private placement until at least 30 days following the completion of the business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Promissory Note &#x2014; Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November&#160;5, 2024, the Sponsor agreed to loan the Company up to an aggregate amount of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20241105_z05FAPdrLPX5"&gt;500,000 &lt;/span&gt;to be used, in part, for transaction costs incurred in connection with the IPO (the &#x201c;Promissory Note&#x201d;). The Promissory Note is unsecured, interest-free and due on the date on which the Company closes the IPO. The loan was repaid upon the closing of the IPO out of the offering proceeds not held in the Trust Account on March&#160;19, 2025. As of May&#160;31, 2026 and November 30, 2025, the Company had no outstanding loan balance under the Promissory Note.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Working Capital Loans&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company&#x2019;s officers and directors, or their affiliates/designees may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. If the Company completes the initial Business Combination, it would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment. &lt;span id="xdx_90F_ecustom--LenderDescription_c20251201__20260531_zaJZWJ8MPqP3" title="Lender description"&gt;Up to $1,500,000 of such working capital loans (&#x201c;Working Capital Loans&#x201d;) may be convertible into private units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination. The units would be identical to the Private Placement Units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of May&#160;31, 2026 and November&#160;30, 2025, the Company had no
borrowings under the Working Capital Loans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;
 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Administrative Services Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company entered into an Administrative
Services Agreement with the Sponsor on November&#160;5, 2024, commencing on the effective date of the registration statement of the
initial public offering through the earlier of the consummation by the Company of an initial business combination or the
Company&#x2019;s liquidation, to pay the Sponsor a total of $&lt;span id="xdx_903_eus-gaap--AdministrativeFeesExpense_pp0p0_c20251201__20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z8nf8VzOdkog" title="Administrative Expense"&gt;20,000&lt;/span&gt;
per month for office space and administrative and support services. On February&#160;12, 2025, the Company and the Sponsor entered
into the First Amendment to the Administrative Services Agreement, pursuant to which the monthly fee was amended to $&lt;span id="xdx_90F_eus-gaap--AdministrativeFeesExpense_pp0p0_c20251201__20260531_zNTCIdyFb8bd" title="Administrative Expense"&gt;15,000&lt;/span&gt;.
On March&#160;7, 2025, the Company and the Sponsor entered into the Second Amendment to the Administrative Services Agreement,
pursuant to which the monthly fee was amended to $&lt;span id="xdx_900_eus-gaap--AdministrativeFeesExpense_pp0p0_c20251201__20260531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--ProductOrServiceAxis__us-gaap--AdministrativeServiceMember_zGQMbgurKHXb" title="Administrative Expense"&gt;20,000&lt;/span&gt;.
The Company incurred $&lt;span id="xdx_904_ecustom--PaymentToSponsor_c20260301__20260531_zlLmgR1zEm42" title="Payment to sponsor"&gt;60,000&lt;/span&gt;
and $&lt;span id="xdx_90D_ecustom--PaymentToSponsor_c20250301__20250531_zQ4X82RbVHR3" title="Payment to sponsor"&gt;120,000&lt;/span&gt;
for the three and six months ended May&#160;31, 2026, respectively . The Company incurred and paid the Sponsor $&lt;span id="xdx_90D_ecustom--PaymentToSponsor_c20251201__20260531_zsXvhUa428cg" title="Payment to sponsor"&gt;&lt;span id="xdx_90B_ecustom--PaymentToSponsor_c20241201__20250531_z9hDTWusCmpb" title="Payment to sponsor"&gt;51,400&lt;/span&gt;&lt;/span&gt; for each of the three and six months ended May 31, 2025. As of May&#160;31, 2026 and November&#160;30, 2025, the
Company accrued $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20260531_z0kxqdC2cqj5" title="Accrued administrative expense"&gt;180,000&lt;/span&gt;
and $&lt;span id="xdx_909_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20251130_zWOqNatwv3fa" title="Accrued administrative expense"&gt;60,000&lt;/span&gt;
on the accompanying balance sheets, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Due to Related Party&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Sponsor paid certain transaction costs on
behalf of the Company. These amounts are due on demand and non-interest bearing. As of May&#160;31, 2026 and November 30, 2025, the amount
due to the related party was $&lt;span id="xdx_904_ecustom--DueToRelatedParty_iI_c20260531_zFckC2xP51Z4" title="Due to related party"&gt;174,352&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--DueToRelatedParty_iI_c20251130_zmoi4424Z3H2" title="Due to related party"&gt;0&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; 

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-012024-11-05_custom_FounderMember"
      decimals="INF"
      id="Fact000705"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-11-012024-11-05_custom_FounderMember"
      decimals="0"
      id="Fact000707"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-05_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000709"
      unitRef="USDPShares">0.0145</us-gaap:SharePrice>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-02-032025-02-12_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000711"
      unitRef="Shares">2415000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:SharePrice
      contextRef="AsOf2025-02-12_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000713"
      unitRef="USDPShares">0.0104</us-gaap:SharePrice>
    <CIK0002047455:AdjustedFounderShares
      contextRef="From2025-03-012025-03-17"
      decimals="INF"
      id="Fact000715"
      unitRef="Shares">2898000</CIK0002047455:AdjustedFounderShares>
    <CIK0002047455:SharesSubjectToForfeiture
      contextRef="From2025-03-012025-03-17_custom_FounderMember"
      decimals="INF"
      id="Fact000717"
      unitRef="Shares">378000</CIK0002047455:SharesSubjectToForfeiture>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-11-05"
      decimals="0"
      id="Fact000718"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <CIK0002047455:LenderDescription contextRef="From2025-12-01to2026-05-31" id="Fact000720">Up to $1,500,000 of such working capital loans (&#x201c;Working Capital Loans&#x201d;) may be convertible into private units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination. The units would be identical to the Private Placement Units.</CIK0002047455:LenderDescription>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-12-012026-05-31_custom_SponsorMember"
      decimals="0"
      id="Fact000723"
      unitRef="USD">20000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000725"
      unitRef="USD">15000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="From2025-12-012026-05-31_custom_SponsorMember_us-gaap_AdministrativeServiceMember"
      decimals="0"
      id="Fact000727"
      unitRef="USD">20000</us-gaap:AdministrativeFeesExpense>
    <CIK0002047455:PaymentToSponsor
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000729"
      unitRef="USD">60000</CIK0002047455:PaymentToSponsor>
    <CIK0002047455:PaymentToSponsor
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000731"
      unitRef="USD">120000</CIK0002047455:PaymentToSponsor>
    <CIK0002047455:PaymentToSponsor
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000733"
      unitRef="USD">51400</CIK0002047455:PaymentToSponsor>
    <CIK0002047455:PaymentToSponsor
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000735"
      unitRef="USD">51400</CIK0002047455:PaymentToSponsor>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000737"
      unitRef="USD">180000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000739"
      unitRef="USD">60000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <CIK0002047455:DueToRelatedParty
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000741"
      unitRef="USD">174352</CIK0002047455:DueToRelatedParty>
    <CIK0002047455:DueToRelatedParty
      contextRef="AsOf2025-11-30"
      decimals="0"
      id="Fact000743"
      unitRef="USD">0</CIK0002047455:DueToRelatedParty>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000745">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zKf2ZBNG7Q3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 6 &#x2014; &lt;span id="xdx_824_zwLuxJAZas6a"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Various social and political circumstances in the U.S. and around the world (including tariffs, rising trade tensions between the U.S. and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries), may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of these circumstances and the ongoing global conflicts and/or other future global conflicts, the Company&#x2019;s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company&#x2019;s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and potential future sanctions on the world economy and the specific impact on the Company&#x2019;s financial position, results of operations or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The holders of the Founder Shares issued and outstanding as of March&#160;19, 2025, as well as the holders of the private units and any shares of the Company&#x2019;s insiders, officers, directors or their affiliates may be issued in payment of working capital loans and extension loans made to the Company (and any shares of ordinary shares issuable upon conversion of the underlying the private rights), will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of the registration statement. The holders of a majority of these securities are entitled to make demands that the Company register such securities. Both the holders of the Founder Shares and the holders of the private units as well as shares issued in payment of working capital loans made to the Company, if applicable, will have the ability to elect to exercise these registration rights at any time after the consummation of an initial business combination. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the consummation of an initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Underwriting Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has granted SPAC Advisory Partners (&#x201c;SAP&#x201d;), the representative of the underwriters, a 45-day option from the date of the registration statement to purchase up to &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20251201__20260531__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zUdhXT1rUoGj" title="Sale of units in initial public offering"&gt;1,080,000&lt;/span&gt; additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. The underwriter fully excised its over-allotment option on March&#160;19, 2025.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The underwriter is entitled to a cash underwriting
discount of &lt;span id="xdx_90A_ecustom--PercentageOfCashUnderwritingCommission_dp_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6NZgfqJauAe" title="Percentage of cash underwritng commission"&gt;0.75&lt;/span&gt;% on the first $&lt;span id="xdx_907_ecustom--GrossProceedsFromProposedPublicOffering_pp0p0_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zTXCI0w5ctq1" title="Gross proceeds from proposed Public Offering"&gt;69,000,000&lt;/span&gt; of the gross proceeds from the IPO, plus &lt;span id="xdx_900_ecustom--PercentageOfUnderwritingDeferredCommission_dp_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zBcIcGXdvKL3" title="Percentage of underwriting deferred Commission"&gt;0.50&lt;/span&gt;% on the remaining $&lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250303__20250319_zPD8n7uuTZE5" title="Sale of units in initial public offering"&gt;13,800,000&lt;/span&gt;, totaling $&lt;span id="xdx_908_ecustom--OverallotmentOptionEstimated_pp0p0_c20250303__20250319_zuBATbp7dft7" title="Over-allotment option estimated"&gt;586,500&lt;/span&gt;
including the full excise of over-allotment option by the underwriter. In addition, the underwriter is entitled to a deferred fee of
&lt;span id="xdx_906_ecustom--PercentageOfDeferredFee_dp_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z8oBzDNKHYRk" title="Percentage of deferred fee"&gt;4.0&lt;/span&gt;% of the gross proceeds of the IPO, or $&lt;span id="xdx_908_ecustom--GrossProceedsFromInitialPublicOffering_pp0p0_c20241201__20251130__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zGlsphXPabs5" title="Gross proceeds from Initial Public Offering"&gt;3,312,000&lt;/span&gt;, which was recorded as a non-current liability as of May&#160;31, 2026. On March
3, 2026, the Company entered into Amendment No.1 to the Underwriting Agreement, which revised the calculation and payment terms of the
deferred underwriting commission. Pursuant to the amendment, the deferred underwriting commission will be payable from the trust account
upon consummation of the Company&#x2019;s initial business combination and equals 4.00% of the gross proceeds from the sale of the firm units
and option units, subject to a cap equal to 4.00% of the funds remaining in the trust account after giving effect to all properly submitted
redemptions in connection with the initial business combination. The amendment also clarifies that the underwriters may waive the deferred
underwriting commission prior to the consummation of the Company&#x2019;s initial business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Right of First Refusal&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has granted SAP a right of first refusal for a period commencing from the consummation of the IPO until the earlier of (i) 10 months after the consummation of the initial business combination (or the liquidation of the Trust Account in the event that the Company fails to consummate its initial business combination within the prescribed time period) or (ii) 36 months after the consummation of the IPO in accordance with FINRA Rule&#160;5110(g)(6)(A) to act as lead financial advisor, capital markets advisor, underwriter and/or private placement agent in connection with any initial business combination or in connection with any financing that occurs between the closing of the IPO and the date that is the earlier of (i) 10 months after the closing of the initial business combination or (ii) 36 months after the consummation of the IPO.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Finder&#x2019;s Fee Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 22, 2025, the Company entered into the Finder&#x2019;s Fee Agreement with Hugh Grow Investment Ltd. (the &#x201c;Finder&#x201d;). Pursuant to the Finder&#x2019;s Fee Agreement, the Company agreed to pay the Finder a one-time, non-refundable retainer fee in the amount of $&lt;span id="xdx_906_ecustom--NonrefundableRetainerFee_iI_c20250422_zvdtabK97Gze" title="Non refundable retainer fee"&gt;350,000&lt;/span&gt;, payable upon the execution of Finder&#x2019;s Fee Agreement (the &#x201c;Retainer Fee&#x201d;). The Company also agreed to pay the Finder a success fee in the amount of $&lt;span id="xdx_90B_ecustom--SuccessFee_iI_c20250422_zU7zMFwghO0d" title="Success fee"&gt;3,500,000&lt;/span&gt;, payable upon the closing (or closings) of a potential target company introduced by the Finder. In addition, the Company agreed to reimburse the Finder on a monthly basis for all reasonable, actual, and verifiable out-of-pocket expenses incurred in connection with the Finder&#x2019;s engagement under the agreement, provided that such expenses shall not exceed $&lt;span id="xdx_907_ecustom--FindersFeeAgreementToExpenses_iI_c20250422_zIV9O5S7ktIh" title="Finders fee agreement to expenses"&gt;150,000&lt;/span&gt; without the Company&#x2019;s prior written approval. On April 29, 2025, the Company entered into an amendment to the Finder&#x2019;s Fee Agreement, pursuant to which the Retainer Fee was adjusted to $&lt;span id="xdx_905_ecustom--RetainerFee_iI_c20250429_zV2r11ThhD1l" title="Retainer fee"&gt;150,000&lt;/span&gt;. On July 18, 2025, the Company entered into the second amendment to the Finder&#x2019;s Fee Agreement, pursuant to which the Success Fee was amended to consist of &lt;span id="xdx_907_ecustom--SuccessFeeShares_iI_c20250718_zTvonLlnmwC7" title="Success Fee, shares"&gt;1,560,000&lt;/span&gt; ordinary shares (the &#x201c;Finder Shares&#x201d;) of the surviving publicly traded company (the &#x201c;Surviving Company&#x201d;). Sixty (60%) of the Finder Shares shall be subject to lock-up restriction for six months from the date of issuance, while Forty (40%) of Finder Shares shall be free from any lock-up restriction, subject to the applicable securities laws and regulations. As of May&#160;31, 2026, the Retainer Fee had been paid in full, and there was no outstanding balance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company acknowledges and agrees that the Finder
is not a registered broker-dealer under U.S. securities laws, and is not acting as a broker-dealer in connection with the transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Acknowledgement Agreement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 18, 2025, Quartzsea, the Finder, and Broadway Tech entered into an acknowledgement agreement (the &#x201c;Acknowledgement Agreement&#x201d;) pursuant to which Broadway Tech acknowledged and agreed to cause the Surviving Company to issue the Finder Shares to the Finder in accordance with the terms of the Acknowledgement Agreement at the closing of the Business Combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pursuant to the New Merger Agreement, the parties acknowledged that
Hugh Grow Investment Ltd. claimed to be entitled to a finder's fee in connection with the Business Combination. Upon the closing of the
Business Combination, the Purchaser is obligated to pay the Finder a fee currently estimated at 3% of the total consideration payable
in the Acquisition Merger.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-12-012026-05-31_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000747"
      unitRef="Shares">1080000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <CIK0002047455:PercentageOfCashUnderwritingCommission
      contextRef="From2024-12-012025-11-30_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000750"
      unitRef="Pure">0.0075</CIK0002047455:PercentageOfCashUnderwritingCommission>
    <CIK0002047455:GrossProceedsFromProposedPublicOffering
      contextRef="From2024-12-012025-11-30_us-gaap_IPOMember"
      decimals="0"
      id="Fact000752"
      unitRef="USD">69000000</CIK0002047455:GrossProceedsFromProposedPublicOffering>
    <CIK0002047455:PercentageOfUnderwritingDeferredCommission
      contextRef="From2024-12-012025-11-30_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000754"
      unitRef="Pure">0.0050</CIK0002047455:PercentageOfUnderwritingDeferredCommission>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-03-032025-03-19"
      decimals="INF"
      id="Fact000756"
      unitRef="Shares">13800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <CIK0002047455:OverallotmentOptionEstimated
      contextRef="From2025-03-032025-03-19"
      decimals="0"
      id="Fact000758"
      unitRef="USD">586500</CIK0002047455:OverallotmentOptionEstimated>
    <CIK0002047455:PercentageOfDeferredFee
      contextRef="From2024-12-012025-11-30_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000760"
      unitRef="Pure">0.040</CIK0002047455:PercentageOfDeferredFee>
    <CIK0002047455:GrossProceedsFromInitialPublicOffering
      contextRef="From2024-12-012025-11-30_us-gaap_IPOMember"
      decimals="0"
      id="Fact000762"
      unitRef="USD">3312000</CIK0002047455:GrossProceedsFromInitialPublicOffering>
    <CIK0002047455:NonrefundableRetainerFee
      contextRef="AsOf2025-04-22"
      decimals="0"
      id="Fact000764"
      unitRef="USD">350000</CIK0002047455:NonrefundableRetainerFee>
    <CIK0002047455:SuccessFee
      contextRef="AsOf2025-04-22"
      decimals="0"
      id="Fact000766"
      unitRef="USD">3500000</CIK0002047455:SuccessFee>
    <CIK0002047455:FindersFeeAgreementToExpenses
      contextRef="AsOf2025-04-22"
      decimals="0"
      id="Fact000768"
      unitRef="USD">150000</CIK0002047455:FindersFeeAgreementToExpenses>
    <CIK0002047455:RetainerFee
      contextRef="AsOf2025-04-29"
      decimals="0"
      id="Fact000770"
      unitRef="USD">150000</CIK0002047455:RetainerFee>
    <CIK0002047455:SuccessFeeShares
      contextRef="AsOf2025-07-18"
      decimals="INF"
      id="Fact000772"
      unitRef="Shares">1560000</CIK0002047455:SuccessFeeShares>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000774">&lt;p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zAychljqDfl1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 7 &#x2014; &lt;span id="xdx_827_zoroKeZrGSHf"&gt;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Ordinary shares&lt;/i&gt;&lt;/b&gt; &#x2014; The
Company is authorized to issue up to &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20260531_zBQ4ul3wvhei"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20251130_zEU13kZJQUW1"&gt;500,000,000&lt;/span&gt; &lt;/span&gt;ordinary
shares, par value $&lt;span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20260531_z0jm4I3hhRTh"&gt;&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20251130_zwVN7uLQXefj"&gt;0.0001&lt;/span&gt; &lt;/span&gt;per
share. Holders of ordinary shares are entitled to one vote for each share held on all matters to be voted on by the shareholders,
except as required by law. On November&#160;5, 2024, the Company issued to the Sponsor &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241101__20241105__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zEW0ei3kof49"&gt;1,725,000 &lt;/span&gt;ordinary
shares for $&lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0d_c20241101__20241105__us-gaap--RelatedPartyTransactionAxis__custom--FounderMember_zd4GkuoVpn7c"&gt;25,000&lt;/span&gt;.
On February&#160;12, 2025, the Company and the Sponsor entered into the First Amendment to the Subscription Agreement, pursuant to
which the purchased amount of shares was adjusted to &lt;span id="xdx_90F_eus-gaap--ConversionOfStockSharesConverted1_c20250203__20250212__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FounderSharesMember_ztf7VS2x3tEj"&gt;2,415,000 &lt;/span&gt;ordinary
shares. On March&#160;17, 2025, the Company and the Sponsor entered into the Second Amendment to the Subscription Agreement,
pursuant to which the purchased amount of Founder Shares was adjusted to &lt;span id="xdx_90C_ecustom--AdjustedFounderShares_c20250301__20250317_zOyYWtx7csF6" title="Adjusted founder shares"&gt;2,898,000&lt;/span&gt;.
At May&#160;31, 2026 and November 30, 2025, there were &lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_c20260531_zlUCQ4ZbWfp7"&gt;&lt;span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_c20260531_zsPWsTuy7PQ2"&gt;&lt;span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20251130_zRi51LohCK91"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20251130_zcdEgqLwIle"&gt;3,129,900&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
shares outstanding.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

 



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Rights &lt;/i&gt;&lt;/b&gt;&#x2014; Each holder of a right will receive one-fifth (1/5) of one ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon conversion of the rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination, as the consideration related thereto has been included in the Unit purchase price paid for by investors in the IPO. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per ordinary share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary shares basis and each holder of a right will be required to affirmatively covert its rights in order to receive one share underlying each right (without paying additional consideration). The shares issuable upon conversion of the rights will be freely tradable (except to the extent held by affiliates of the Company).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000775"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000776"
      unitRef="Shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000777"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000778"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-11-012024-11-05_custom_FounderMember"
      decimals="INF"
      id="Fact000779"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-11-012024-11-05_custom_FounderMember"
      decimals="0"
      id="Fact000780"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-02-032025-02-12_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000781"
      unitRef="Shares">2415000</us-gaap:ConversionOfStockSharesConverted1>
    <CIK0002047455:AdjustedFounderShares
      contextRef="From2025-03-012025-03-17"
      decimals="INF"
      id="Fact000783"
      unitRef="Shares">2898000</CIK0002047455:AdjustedFounderShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000784"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000785"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000786"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-11-30"
      decimals="INF"
      id="Fact000787"
      unitRef="Shares">3129900</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000790">&lt;p id="xdx_80D_eus-gaap--SegmentReportingDisclosureTextBlock_zWKWDUAZkaNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 8 &#x2014; &lt;span id="xdx_829_z3EsmT9Bgsec"&gt;Segment Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC Topic 280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker, or group, in deciding how to allocate resources and assess performance. The Company has adopted the guidance in ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in the accompanying financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s chief operating decision maker has been identified as the Chief Executive Officer and Chairwoman (&#x201c;CODM&#x201d;), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment. The Company&#x2019;s CODM does not review assets by segment in her evaluation and therefore assets by segment are not disclosed below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z1zwUqt8D4T4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_z4u2IPyxODP1" style="display: none"&gt;Schedule of Segment information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20260301__20260531_zVqz4xrAQPd7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20250301__20250531_zP82DkfpwGe6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20251201__20260531_zbIPoEliSzIh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20241201__20250531_zgWbdtJo4QT9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
May&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&lt;br/&gt;
Six Months Ended&lt;br/&gt;
May&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherGeneralAndAdministrativeExpense_zqWrou7DF86" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;196,589&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;727,747&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;427,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;761,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--InterestIncomeExpensesNet_zR6yMnbUTYw7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Interest earned on investments held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;770,237&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;692,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,530,146&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;692,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The key measures of segment profit or loss reviewed by the CODM are general and administrative expenses and interest earned on investments held in Trust Account. General and administrative expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Interest earned on investments held in Trust Account are reviewed to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt; 



 

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000792">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_z1zwUqt8D4T4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Segment Information (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_z4u2IPyxODP1" style="display: none"&gt;Schedule of Segment information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20260301__20260531_zVqz4xrAQPd7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20250301__20250531_zP82DkfpwGe6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20251201__20260531_zbIPoEliSzIh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20241201__20250531_zgWbdtJo4QT9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&lt;br/&gt;
Three Months Ended&lt;br/&gt;
May&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For&#160;the&lt;br/&gt;
Six Months Ended&lt;br/&gt;
May&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherGeneralAndAdministrativeExpense_zqWrou7DF86" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;General and administrative expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;196,589&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;727,747&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;427,450&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;761,251&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--InterestIncomeExpensesNet_zR6yMnbUTYw7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Interest earned on investments held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;770,237&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;692,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,530,146&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;692,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000794"
      unitRef="USD">196589</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000795"
      unitRef="USD">727747</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000796"
      unitRef="USD">427450</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000797"
      unitRef="USD">761251</us-gaap:OtherGeneralAndAdministrativeExpense>
    <CIK0002047455:InterestIncomeExpensesNet
      contextRef="From2026-03-012026-05-31"
      decimals="0"
      id="Fact000799"
      unitRef="USD">770237</CIK0002047455:InterestIncomeExpensesNet>
    <CIK0002047455:InterestIncomeExpensesNet
      contextRef="From2025-03-012025-05-31"
      decimals="0"
      id="Fact000800"
      unitRef="USD">692945</CIK0002047455:InterestIncomeExpensesNet>
    <CIK0002047455:InterestIncomeExpensesNet
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000801"
      unitRef="USD">1530146</CIK0002047455:InterestIncomeExpensesNet>
    <CIK0002047455:InterestIncomeExpensesNet
      contextRef="From2024-12-012025-05-31"
      decimals="0"
      id="Fact000802"
      unitRef="USD">692945</CIK0002047455:InterestIncomeExpensesNet>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-12-01to2026-05-31" id="Fact000805">&lt;p id="xdx_801_eus-gaap--SubsequentEventsTextBlock_zk2ww6hBtR92" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 9 &#x2014; &lt;span id="xdx_821_zDA4MKOoaXFg"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date when these unaudited condensed consolidated financial statements were issued. Based on this review, the Company identified the following subsequent events that would require adjustment or disclosure in the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;June 2026 Extraordinary General Meeting and Extension of the Combination
Period&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 23, 2026, Quartzsea held an extraordinary
general meeting at which its shareholders approved, among other things, an amendment to the Existing Charter extending the date by which
Quartzsea must consummate an initial business combination from June 19, 2026 to October 19, 2026, or such earlier date as the Quartzsea
Board may determine, with Quartzsea permitted to extend such date further on a month-to-month basis for up to four additional one-month
periods (the &#x201c;Extension Amendment&#x201d;). Quartzsea&#x2019;s shareholders also approved a corresponding amendment to the Investment
Management Trust Agreement, dated March 17, 2025, with Continental Stock Transfer &amp;amp; Trust Company, extending the trust termination
date on the same terms, and an adjournment proposal. Pursuant to the Trust Agreement amendment, for each one-month extension Quartzsea
will deposit into the trust account the lesser of (i) $&lt;span id="xdx_90F_ecustom--Deposit_iI_c20260623_zVMFqHAAL8Wj" title="Deposit"&gt;175,000&lt;/span&gt; or (ii) $&lt;span id="xdx_907_ecustom--OutstandingPublicShare_iI_c20260531_zytc6TqsVlid" title="Outstanding public share"&gt;0.033&lt;/span&gt; per outstanding public share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the Business Combination Agreement,
Eight Directions is responsible for funding all extension contributions required in connection with any extension of Quartzsea&#x2019;s
deadline to consummate an initial business combination. In accordance with such obligation, Eight Directions remits each applicable extension
contribution to Quartzsea&#x2019;s Trust Account, following which Quartzsea causes the applicable payment to be made in accordance with
the Trust Agreement. The first extension contribution of $&lt;span id="xdx_90D_ecustom--Deposit_iI_c20260625_zs9oQ36DMZ16" title="Deposit"&gt;175,000&lt;/span&gt; was funded by Eight Directions and deposited into the trust account
on June 25, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the extraordinary general
meeting, holders of &lt;span id="xdx_90F_ecustom--ExtraordinaryGeneralMeeting_c20251201__20260531_zDT9goUrArmk" title="Extraordinary general meeting"&gt;1,275,382&lt;/span&gt; Quartzsea ordinary shares properly exercised their redemption rights. Such shares were redeemed at a price
of approximately $&lt;span id="xdx_906_ecustom--AggregatePerShare_iI_c20260531_zNAFN8h2aB84" title="Aggregate per share"&gt;10.50&lt;/span&gt; per share, for an aggregate redemption payment of $&lt;span id="xdx_90A_ecustom--PaymentRedemptionValue_c20251201__20260531_zT6st0969nbk" title="Payment redemption value"&gt;13,391,956&lt;/span&gt; from the trust account. Following
such redemptions, &lt;span id="xdx_903_ecustom--PaymentRedemptionShares_c20251201__20260531_zts24HMoyEGc" title="Payment redemption shares"&gt;10,134,518&lt;/span&gt; Quartzsea ordinary shares were issued and outstanding, and $&lt;span id="xdx_903_ecustom--Deposit_iI_c20260531_zuqMmPusgsn7" title="Deposit"&gt;73,550,934&lt;/span&gt; remained on deposit
in the Trust Account.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Issuance of Promissory Note&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On July 13, 2026, the Company issued to the
Sponsor a promissory note in an aggregate amount of up to $&lt;span id="xdx_90C_ecustom--AggregateAmount_iI_c20260713_z853CPo4B5V6" title="Aggregate amount"&gt;250,000&lt;/span&gt;,
to be used, in part, for working capital and transaction expenses related to the business combination (the &#x201c;July 2026
Promissory Note&#x201d;). The July 2026 Promissory Notes is unsecured, interest-free and due on the date on which the Company closes
its initial business combination. As of July 13, 2026, $&lt;span id="xdx_90E_ecustom--DueToRelatedParty_iI_c20260713_zLao4Xd5GuGj" title="Due to related party"&gt;224,352&lt;/span&gt;
had been funded and recorded as &#x201c;Due to related party&#x201d; on the balance sheet, and such amount will be converted into the
July 2026 Promissory Note.&lt;/p&gt;
</us-gaap:SubsequentEventsTextBlock>
    <CIK0002047455:Deposit
      contextRef="AsOf2026-06-23"
      decimals="0"
      id="Fact000807"
      unitRef="USD">175000</CIK0002047455:Deposit>
    <CIK0002047455:OutstandingPublicShare
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000809"
      unitRef="USDPShares">0.033</CIK0002047455:OutstandingPublicShare>
    <CIK0002047455:Deposit
      contextRef="AsOf2026-06-25"
      decimals="0"
      id="Fact000811"
      unitRef="USD">175000</CIK0002047455:Deposit>
    <CIK0002047455:ExtraordinaryGeneralMeeting
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000813"
      unitRef="Shares">1275382</CIK0002047455:ExtraordinaryGeneralMeeting>
    <CIK0002047455:AggregatePerShare
      contextRef="AsOf2026-05-31"
      decimals="INF"
      id="Fact000815"
      unitRef="USDPShares">10.50</CIK0002047455:AggregatePerShare>
    <CIK0002047455:PaymentRedemptionValue
      contextRef="From2025-12-01to2026-05-31"
      decimals="0"
      id="Fact000817"
      unitRef="USD">13391956</CIK0002047455:PaymentRedemptionValue>
    <CIK0002047455:PaymentRedemptionShares
      contextRef="From2025-12-01to2026-05-31"
      decimals="INF"
      id="Fact000819"
      unitRef="Shares">10134518</CIK0002047455:PaymentRedemptionShares>
    <CIK0002047455:Deposit
      contextRef="AsOf2026-05-31"
      decimals="0"
      id="Fact000821"
      unitRef="USD">73550934</CIK0002047455:Deposit>
    <CIK0002047455:AggregateAmount
      contextRef="AsOf2026-07-13"
      decimals="0"
      id="Fact000823"
      unitRef="USD">250000</CIK0002047455:AggregateAmount>
    <CIK0002047455:DueToRelatedParty
      contextRef="AsOf2026-07-13"
      decimals="0"
      id="Fact000825"
      unitRef="USD">224352</CIK0002047455:DueToRelatedParty>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000212"
          xlink:label="Fact000212"
          xlink:type="locator"/>
        <link:footnote id="Footnote000243" xlink:label="Footnote000243" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Ordinary shares have been retroactively restated to reflect two amendments to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares initially from 1,725,000 to 2,415,000, then to 2,898,000 shares for $25,000.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000212"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000214"
          xlink:label="Fact000214"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000214"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000216"
          xlink:label="Fact000216"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000216"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000218"
          xlink:label="Fact000218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000218"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000220"
          xlink:label="Fact000220"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000220"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000222"
          xlink:label="Fact000222"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000222"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000224"
          xlink:label="Fact000224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000224"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000226"
          xlink:label="Fact000226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000226"
          xlink:to="Footnote000243"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000286"
          xlink:label="Fact000286"
          xlink:type="locator"/>
        <link:footnote id="Footnote000338" xlink:label="Footnote000338" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Ordinary shares have been retroactively restated to reflect two amendments to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares initially from 1,725,000 to 2,415,000, then to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000286"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000287"
          xlink:label="Fact000287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000287"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000288"
          xlink:label="Fact000288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000288"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000289"
          xlink:label="Fact000289"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000289"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000298"
          xlink:label="Fact000298"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000298"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000299"
          xlink:label="Fact000299"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000299"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000300"
          xlink:label="Fact000300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000300"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000301"
          xlink:label="Fact000301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000301"
          xlink:to="Footnote000338"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
